CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | 3-(3,4-substituted-phenyl)-1,1-dimethylurea |
|
Accession: | CHEBI:157693
|
browse the term
|
Definition: | A member of the class of phenylureas that is urea in which one of the nitrogens is substituted by two methyl groups while the other is substituted by a phenyl group which carries two unspecified groups at positions 3 and 4 of the phenyl ring. |
Synonyms: | related_synonym: | 3-(3,4-substituted-phenyl)-1,1-dimethylureas; Formula=C9H10N2OR2; N'-(3,4-substituted-phenyl)-N,N-dimethylurea; N'-(3,4-substituted-phenyl)-N,N-dimethylureas; SMILES=CN(C)C(=O)NC1=CC([*])=C([*])C=C1; a 1,1-dimethyl-3-phenylurea |
| xref: | MetaCyc:11-Dimethyl-3-Phenylureas; PMID:24123738 |
|
|
|
G |
A3galt2 |
alpha 1,3-galactosyltransferase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of A3GALT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:146,933,592...146,945,882
Ensembl chr 5:146,933,592...146,945,880
|
|
G |
Aagab |
alpha- and gamma-adaptin binding protein |
increases expression |
EXP |
Diuron results in increased expression of AAGAB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:68,526,063...68,564,604
Ensembl chr 8:68,526,093...68,563,018
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ABCC1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
decreases expression |
EXP |
Diuron results in decreased expression of ABCC5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:84,395,982...84,490,215
Ensembl chr11:84,396,033...84,490,211
|
|
G |
Abhd12 |
abhydrolase domain containing 12, lysophospholipase |
increases expression |
EXP |
Diuron results in increased expression of ABHD12 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:146,630,298...146,690,375
Ensembl chr 3:146,630,299...146,690,375
|
|
G |
Abhd17c |
abhydrolase domain containing 17C, depalmitoylase |
increases expression |
EXP |
Diuron results in increased expression of ABHD17C mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:146,248,505...146,289,465
Ensembl chr 1:146,248,503...146,289,465
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
EXP |
Diuron results in increased expression of ABHD4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:32,888,233...32,906,861
Ensembl chr15:32,894,938...32,906,850
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ABI3BP mRNA Diuron results in decreased expression of ABI3BP mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr11:46,206,932...46,422,791
Ensembl chr11:46,208,075...46,369,577
|
|
G |
Ablim1 |
actin-binding LIM protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ABLIM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:277,853,877...278,043,096
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
increases expression |
EXP |
Diuron results in increased expression of ACAA1A mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 8:128,027,880...128,036,471
Ensembl chr 8:128,027,958...128,036,236
|
|
G |
Acad11 |
acyl-CoA dehydrogenase family, member 11 |
increases expression |
EXP |
Diuron results in increased expression of ACAD11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:112,594,758...112,676,275
Ensembl chr 8:112,594,691...112,676,280
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
increases expression |
EXP |
Diuron results in increased expression of ACAD9 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:122,782,051...122,806,166
Ensembl chr 2:122,782,060...122,805,768
|
|
G |
Acadl |
acyl-CoA dehydrogenase, long chain |
increases expression |
EXP |
Diuron results in increased expression of ACADL mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:73,833,368...73,871,857
Ensembl chr 9:73,833,388...73,871,888
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ACAT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
|
|
G |
Acbd4 |
acyl-CoA binding domain containing 4 |
increases expression |
EXP |
Diuron results in increased expression of ACBD4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:91,186,131...91,200,081
Ensembl chr10:91,187,593...91,196,572
|
|
G |
Acer2 |
alkaline ceramidase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ACER2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:105,230,540...105,279,732
Ensembl chr 5:105,230,580...105,279,731
|
|
G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ACIN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:33,288,369...33,333,256
Ensembl chr15:33,288,374...33,333,417
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ACKR3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 9:97,355,881...97,367,455
Ensembl chr 9:97,355,924...97,367,445
|
|
G |
Ackr4 |
atypical chemokine receptor 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ACKR4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:112,643,838...112,651,668
Ensembl chr 8:112,644,222...112,648,880
|
|
G |
Aco2 |
aconitase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ACO2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:123,102,493...123,145,608
Ensembl chr 7:123,102,468...123,145,635
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
increases expression |
EXP |
Diuron results in increased expression of ACOT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:107,485,088...107,493,082
Ensembl chr 6:107,485,249...107,493,798
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
increases expression |
EXP |
Diuron results in increased expression of ACOT2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:107,460,596...107,468,324
Ensembl chr 6:107,460,668...107,467,487
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
EXP |
Diuron results in increased expression of ACOX1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:104,724,534...104,748,003
Ensembl chr10:104,722,958...104,748,050
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
increases expression |
EXP |
Diuron results in increased expression of ACP5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:23,142,733...23,149,067
Ensembl chr 8:23,142,734...23,148,396
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ACSL1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ACSL4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:113,596,247...113,660,024
Ensembl chr X:113,596,239...113,659,944
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ACSS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:146,420,346...146,470,293
Ensembl chr 3:146,420,346...146,470,293
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ACSS2 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr 3:151,032,925...151,075,856
Ensembl chr 3:151,032,952...151,075,856
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
decreases expression |
EXP |
Diuron results in decreased expression of ACTA1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:56,674,072...56,677,084
Ensembl chr19:56,674,074...56,677,084
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
EXP |
Diuron results in increased expression of ACTA2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Actc1 |
actin, alpha, cardiac muscle 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ACTC1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:105,507,403...105,512,939
Ensembl chr 3:105,507,403...105,512,939
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of ACTG2 mRNA Diuron results in increased expression of ACTG2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:115,215,160...115,239,746
Ensembl chr 4:115,215,060...115,239,723
|
|
G |
Actn1 |
actinin, alpha 1 |
increases expression |
EXP |
Diuron results in increased expression of ACTN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:103,376,557...103,470,497
Ensembl chr 6:103,375,799...103,470,555
|
|
G |
Actr3 |
actin related protein 3 |
increases expression |
EXP |
Diuron results in increased expression of ACTR3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:41,695,520...41,738,622
Ensembl chr13:41,695,183...41,738,658
|
|
G |
Actr3b |
actin related protein 3B |
decreases expression |
EXP |
Diuron results in decreased expression of ACTR3B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:5,644,287...5,672,708
Ensembl chr 4:5,644,260...5,672,708
|
|
G |
Acvr1c |
activin A receptor type 1C |
increases expression |
ISO |
Diuron metabolite results in increased expression of ACVR1C mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 3:44,272,859...44,342,501
Ensembl chr 3:44,270,653...44,342,355
|
|
G |
Adam10 |
ADAM metallopeptidase domain 10 |
increases expression |
EXP |
Diuron results in increased expression of ADAM10 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:77,107,355...77,237,483
Ensembl chr 8:77,107,536...77,237,483
|
|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
decreases expression |
EXP |
Diuron results in decreased expression of ADAM33 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:123,595,018...123,607,549
Ensembl chr 3:123,595,560...123,607,352
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
EXP |
Diuron results in increased expression of ADAM8 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:212,317,510...212,332,895
Ensembl chr 1:212,317,848...212,330,349
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
decreases expression |
EXP |
Diuron results in decreased expression of ADAMTS5 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:25,411,174...25,456,639
Ensembl chr11:25,410,975...25,456,836
|
|
G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ADAMTS9 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:124,660,254...124,860,997
Ensembl chr 4:124,660,262...124,858,250
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ADAMTSL4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:197,803,572...197,815,058
Ensembl chr 2:197,803,584...197,814,808
|
|
G |
Adamtsl5 |
ADAMTS-like 5 |
increases expression |
EXP |
Diuron results in increased expression of ADAMTSL5 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:12,228,706...12,237,382
Ensembl chr 7:12,229,379...12,234,576
|
|
G |
Adcy6 |
adenylate cyclase 6 |
decreases expression |
EXP |
Diuron results in decreased expression of ADCY6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:140,270,678...140,291,722
Ensembl chr 7:140,270,692...140,291,620
|
|
G |
Add3 |
adducin 3 |
decreases expression |
EXP |
Diuron results in decreased expression of ADD3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:273,854,195...273,961,982
Ensembl chr 1:273,854,248...273,961,982
|
|
G |
Adgrf4 |
adhesion G protein-coupled receptor F4 |
increases expression |
EXP |
Diuron results in increased expression of ADGRF4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:20,951,249...20,982,493
Ensembl chr 9:20,951,260...20,982,487
|
|
G |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
increases expression |
EXP |
Diuron results in increased expression of ADGRL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:25,029,037...25,069,146
Ensembl chr19:25,029,037...25,069,142
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
increases expression |
EXP |
Diuron results in increased expression of ADH7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:243,500,540...243,516,865
Ensembl chr 2:243,502,073...243,516,532
|
|
G |
Adi1 |
acireductone dioxygenase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ADI1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:47,940,211...47,947,173
Ensembl chr 6:47,940,183...47,947,230
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases expression |
EXP |
Diuron results in decreased expression of ADIPOQ mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adipor2 |
adiponectin receptor 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
|
|
G |
Aebp1 |
AE binding protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of AEBP1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:86,101,253...86,111,323
Ensembl chr14:86,101,277...86,111,306
|
|
G |
Afdn |
afadin, adherens junction formation factor |
decreases expression |
EXP |
Diuron results in decreased expression of AFDN mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:53,713,873...53,861,918
Ensembl chr 1:53,715,693...53,802,658
|
|
G |
Agmo |
alkylglycerol monooxygenase |
increases expression |
EXP |
Diuron results in increased expression of AGMO mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:56,846,859...57,193,918
Ensembl chr 6:56,846,789...57,193,961
|
|
G |
Agpat3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of AGPAT3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:11,060,584...11,144,806
Ensembl chr20:11,114,164...11,144,806
|
|
G |
Agt |
angiotensinogen |
decreases expression |
EXP |
Diuron results in decreased expression of AGT mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
EXP |
Diuron results in decreased expression of AGTR1A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Ahnak |
AHNAK nucleoprotein |
decreases expression |
EXP |
Diuron results in decreased expression of AHNAK mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:225,184,883...225,429,638
Ensembl chr 1:225,184,939...225,215,015
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects binding multiple interactions |
ISO EXP |
Diuron binds to AHR protein Diuron binds to and results in increased activity of AHR protein; Diuron inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:16705413 PMID:16788953 PMID:18835618 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
increases expression decreases expression |
EXP |
Diuron results in increased expression of AHRR mRNA Diuron results in decreased expression of AHRR mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:31,603,297...31,698,329
Ensembl chr 1:31,603,297...31,698,329
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of AIF1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
|
|
G |
Ajuba |
ajuba LIM protein |
increases expression decreases expression |
EXP ISO |
Diuron results in increased expression of AJUBA mRNA Diuron metabolite results in decreased expression of AJUBA mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr15:33,208,210...33,218,456
Ensembl chr15:33,208,216...33,218,456
|
|
G |
Ak3 |
adenylate kinase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of AK3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:247,144,486...247,169,690
Ensembl chr 1:247,144,491...247,169,693
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
increases expression |
EXP |
Diuron results in increased expression of AKAP12 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:40,816,130...40,906,582
Ensembl chr 1:40,816,107...40,906,581
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
decreases expression |
EXP |
Diuron results in decreased expression of AKAP9 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:27,195,346...27,331,582
Ensembl chr 4:27,195,346...27,331,582
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
increases expression |
EXP |
Diuron results in increased expression of AKR1B1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
|
|
G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
increases expression |
EXP |
Diuron results in increased expression of AKR1B8 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:61,772,064...61,784,637
Ensembl chr 4:61,771,970...61,828,657
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Diuron metabolite results in increased expression of AKR1C2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression |
ISO |
Diuron metabolite results in increased expression of AKR1C3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
Diuron results in increased expression of AKR7A3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:157,801,120...157,813,756
Ensembl chr 5:157,801,163...157,813,756
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
decreases expression |
EXP |
Diuron results in decreased expression of ALCAM mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:50,780,735...50,985,083
Ensembl chr11:50,781,127...50,985,083
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
Diuron results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
EXP |
Diuron metabolite results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 1:127,302,920...127,337,828
Ensembl chr 1:127,301,128...127,337,882
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
decreases expression |
EXP |
Diuron results in decreased expression of ALDH2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ALDH3A1 mRNA Diuron metabolite results in decreased expression of ALDH3A1 mRNA; Diuron results in decreased expression of ALDH3A1 mRNA |
CTD |
PMID:21551480 PMID:24172598 PMID:25152437 |
|
NCBI chr10:47,490,168...47,499,855
Ensembl chr10:47,490,153...47,499,876
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
decreases expression |
EXP |
Diuron results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:47,525,486...47,546,535
Ensembl chr10:47,525,493...47,546,345
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
decreases expression |
EXP |
Diuron results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:108,146,552...108,167,185
Ensembl chr 6:108,146,582...108,167,185
|
|
G |
Alg5 |
ALG5, dolichyl-phosphate beta-glucosyltransferase |
increases expression |
EXP |
Diuron results in increased expression of ALG5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:143,932,242...143,946,472
Ensembl chr 2:143,932,739...143,946,466
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
decreases expression |
EXP |
Diuron results in decreased expression of ALOX12 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:56,851,734...56,864,049
Ensembl chr10:56,851,734...56,864,005
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ALPL mRNA Diuron results in decreased expression of ALPL mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 5:156,086,496...156,141,513
Ensembl chr 5:156,086,497...156,141,537
|
|
G |
Amotl2 |
angiomotin like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of AMOTL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:111,210,261...111,226,217
Ensembl chr 8:111,209,908...111,226,226
|
|
G |
Amt |
aminomethyltransferase |
increases expression |
EXP |
Diuron results in increased expression of AMT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:117,068,388...117,078,633
Ensembl chr 8:117,068,582...117,077,913
|
|
G |
Andpro |
androgen regulated protein |
increases expression |
EXP |
Diuron results in increased expression of ANDPRO mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:143,893,005...143,899,609
Ensembl chr 3:143,893,006...143,899,370
|
|
G |
Angpt4 |
angiopoietin 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ANGPT4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:147,421,724...147,455,670
Ensembl chr 3:147,422,095...147,455,670
|
|
G |
Angptl4 |
angiopoietin-like 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:18,627,814...18,634,043
Ensembl chr 7:18,627,808...18,634,079
|
|
G |
Ank2 |
ankyrin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ANK2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:231,224,643...231,522,655
Ensembl chr 2:231,226,949...231,648,122
|
|
G |
Ankrd10 |
ankyrin repeat domain 10 |
decreases expression |
EXP |
Diuron results in decreased expression of ANKRD10 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:83,205,898...83,229,147
Ensembl chr16:83,206,004...83,228,194
|
|
G |
Ankrd11 |
ankyrin repeat domain 11 |
decreases expression |
EXP |
Diuron results in decreased expression of ANKRD11 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:55,703,831...55,862,446
Ensembl chr19:55,703,824...55,737,500
|
|
G |
Ankrd34b |
ankyrin repeat domain 34B |
increases expression |
EXP |
Diuron results in increased expression of ANKRD34B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:22,000,106...22,016,764
Ensembl chr 2:22,000,106...22,016,030
|
|
G |
Ankrd50 |
ankyrin repeat domain 50 |
increases expression |
EXP |
Diuron results in increased expression of ANKRD50 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:125,289,071...125,323,527
Ensembl chr 2:125,288,693...125,323,454
|
|
G |
Ankrd6 |
ankyrin repeat domain 6 |
decreases expression |
EXP |
Diuron results in decreased expression of ANKRD6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:48,052,610...48,167,568
Ensembl chr 5:48,052,401...48,194,294
|
|
G |
Anks1a |
ankyrin repeat and sterile alpha motif domain containing 1A |
decreases expression |
EXP |
Diuron results in decreased expression of ANKS1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:7,484,550...7,636,498
Ensembl chr20:7,484,550...7,636,497
|
|
G |
Anln |
anillin, actin binding protein |
decreases expression |
ISO |
Diuron results in decreased expression of ANLN mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:23,336,455...23,397,122
Ensembl chr 8:23,337,621...23,390,773
|
|
G |
Anp32e |
acidic nuclear phosphoprotein 32 family member E |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of ANP32E mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:198,040,573...198,057,005
Ensembl chr 2:198,040,536...198,057,003
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
decreases expression |
EXP |
Diuron results in decreased expression of ANPEP mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:141,561,364...141,604,249
Ensembl chr 1:141,561,334...141,604,273
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
increases expression decreases expression |
ISO EXP |
Diuron metabolite results in increased expression of ANTXR2 mRNA Diuron results in decreased expression of ANTXR2 mRNA |
CTD |
PMID:24172598 PMID:25152437 |
|
NCBI chr14:13,191,716...13,331,286
Ensembl chr14:13,192,347...13,274,978
|
|
G |
Anxa1 |
annexin A1 |
decreases expression |
EXP |
Diuron results in decreased expression of ANXA1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
|
|
G |
Anxa2 |
annexin A2 |
decreases expression |
EXP |
Diuron results in decreased expression of ANXA2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
|
|
G |
Anxa4 |
annexin A4 |
decreases expression |
EXP |
Diuron results in decreased expression of ANXA4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
EXP |
Diuron results in increased expression of ANXA6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:40,320,581...40,375,605
Ensembl chr10:40,320,581...40,375,605
|
|
G |
Anxa7 |
annexin A7 |
increases expression |
EXP |
Diuron results in increased expression of ANXA7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:4,254,470...4,281,296
Ensembl chr15:4,254,499...4,281,287
|
|
G |
Anxa9 |
annexin A9 |
decreases expression |
EXP |
Diuron results in decreased expression of ANXA9 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:196,470,318...196,481,568
Ensembl chr 2:196,470,858...196,479,770
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
decreases expression |
EXP |
Diuron results in decreased expression of AOC3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:89,251,370...89,259,313
Ensembl chr10:89,251,370...89,259,313
|
|
G |
Aox1 |
aldehyde oxidase 1 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of AOX1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 9:64,929,682...65,007,872
Ensembl chr 9:64,929,721...65,007,870
|
|
G |
Ap1b1 |
adaptor related protein complex 1 subunit beta 1 |
decreases expression |
EXP |
Diuron results in decreased expression of AP1B1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:85,230,652...85,281,806
Ensembl chr14:85,230,648...85,281,803
|
|
G |
Ap1s2 |
adaptor related protein complex 1 subunit sigma 2 |
decreases expression |
EXP |
Diuron results in decreased expression of AP1S2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr X:32,329,883...32,376,301
Ensembl chr X:32,329,598...32,355,307
|
|
G |
Ap2a2 |
adaptor related protein complex 2 subunit alpha 2 |
decreases expression |
EXP |
Diuron results in decreased expression of AP2A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:214,534,217...214,607,497
Ensembl chr 1:214,534,284...214,606,169
|
|
G |
Apbb1ip |
amyloid beta precursor protein binding family B member 1 interacting protein |
decreases expression |
EXP |
Diuron results in decreased expression of APBB1IP mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr17:90,098,953...90,149,192
Ensembl chr17:90,099,025...90,149,894
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
increases expression |
EXP |
Diuron results in increased expression of APBB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:43,205,047...43,526,968
Ensembl chr14:43,512,901...43,523,080
|
|
G |
Apobec1 |
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
decreases expression |
EXP |
Diuron results in decreased expression of APOBEC1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:155,386,367...155,414,034
Ensembl chr 4:155,386,711...155,401,480
|
|
G |
Apod |
apolipoprotein D |
decreases expression |
EXP |
Diuron results in decreased expression of APOD mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:72,705,204...72,726,263
Ensembl chr11:72,705,129...72,726,301
|
|
G |
Apoe |
apolipoprotein E |
decreases expression |
EXP |
Diuron results in decreased expression of APOE mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
App |
amyloid beta precursor protein |
decreases expression |
EXP |
Diuron results in decreased expression of APP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
EXP |
Diuron results in increased expression of AQP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
|
|
G |
Aqp7 |
aquaporin 7 |
decreases expression |
EXP |
Diuron results in decreased expression of AQP7 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:57,358,297...57,372,332
Ensembl chr 5:57,358,327...57,372,239
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases expression |
ISO EXP |
Dihydrotestosterone inhibits the reaction [Diuron results in increased activity of AR protein]; Diuron inhibits the reaction [Metribolone results in increased activity of AR protein] Diuron results in decreased expression of AR mRNA |
CTD |
PMID:15064155 PMID:18324785 PMID:25152437 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
increases expression |
EXP |
Diuron results in increased expression of ARAP3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:31,112,083...31,138,142
Ensembl chr18:31,112,623...31,136,200
|
|
G |
Areg |
amphiregulin |
decreases expression |
EXP |
Diuron results in decreased expression of AREG mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
|
|
G |
Arf6 |
ADP-ribosylation factor 6 |
increases expression |
EXP |
Diuron results in increased expression of ARF6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:91,697,109...91,698,257
Ensembl chr 6:91,697,109...91,698,255
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ARG1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
|
|
G |
Arhgap20 |
Rho GTPase activating protein 20 |
decreases expression |
EXP |
Diuron results in decreased expression of ARHGAP20 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:56,179,581...56,264,343
Ensembl chr 8:56,179,637...56,264,263
|
|
G |
Arhgap24 |
Rho GTPase activating protein 24 |
increases expression |
EXP |
Diuron results in increased expression of ARHGAP24 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:8,383,211...8,600,526
Ensembl chr14:8,383,214...8,600,512
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
decreases expression |
EXP |
Diuron results in decreased expression of ARHGDIB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:170,913,920...170,932,789
Ensembl chr 4:170,913,923...170,932,618
|
|
G |
Arhgef18 |
Rho/Rac guanine nucleotide exchange factor 18 |
increases expression |
EXP |
Diuron results in increased expression of ARHGEF18 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:1,889,252...1,998,128
Ensembl chr12:1,889,331...1,998,127
|
|
G |
Arhgef25 |
Rho guanine nucleotide exchange factor 25 |
increases expression |
EXP |
Diuron results in increased expression of ARHGEF25 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:70,469,304...70,476,633
Ensembl chr 7:70,469,312...70,476,340
|
|
G |
Arhgef26 |
Rho guanine nucleotide exchange factor 26 |
increases expression |
EXP |
Diuron results in increased expression of ARHGEF26 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:27,107,263...27,236,336
Ensembl chr 2:27,107,318...27,236,672
|
|
G |
Arhgef40 |
Rho guanine nucleotide exchange factor 40 |
decreases expression |
EXP |
Diuron results in decreased expression of ARHGEF40 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr15:28,377,916...28,403,090
Ensembl chr15:28,377,996...28,403,090
|
|
G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor 6 |
decreases expression |
EXP |
Diuron results in decreased expression of ARHGEF6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:159,722,031...159,841,344
Ensembl chr X:159,723,866...159,841,072
|
|
G |
Arl11 |
ADP-ribosylation factor like GTPase 11 |
decreases expression |
EXP |
Diuron results in decreased expression of ARL11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:41,639,985...41,645,685
Ensembl chr15:41,643,541...41,645,685
|
|
G |
Arl4d |
ADP-ribosylation factor like GTPase 4D |
decreases expression |
EXP |
Diuron results in decreased expression of ARL4D mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:89,577,556...89,580,368
Ensembl chr10:89,578,212...89,580,368
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
increases expression |
EXP |
Diuron results in increased expression of ARPC1B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:11,252,300...11,265,849
Ensembl chr12:11,252,296...11,265,865
|
|
G |
Arpc2 |
actin related protein 2/3 complex, subunit 2 |
increases expression |
EXP |
Diuron results in increased expression of ARPC2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:81,518,163...81,548,871
Ensembl chr 9:81,518,176...81,548,871
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
EXP |
Diuron results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:8,732,907...8,745,445
Ensembl chr 2:8,732,932...8,743,069
|
|
G |
Art3 |
ADP-ribosyltransferase 3 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ART3 mRNA Diuron results in decreased expression of ART3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr14:17,143,037...17,225,389
Ensembl chr14:17,143,040...17,225,389
|
|
G |
Asb8 |
ankyrin repeat and SOCS box-containing 8 |
increases expression |
EXP |
Diuron results in increased expression of ASB8 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:139,724,337...139,760,410
Ensembl chr 7:139,724,346...139,734,568
|
|
G |
Ascl3 |
achaete-scute family bHLH transcription factor 3 |
increases expression |
EXP |
Diuron results in increased expression of ASCL3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:174,351,413...174,355,590
|
|
G |
Asgr2 |
asialoglycoprotein receptor 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ASGR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:56,710,446...56,723,608
Ensembl chr10:56,710,464...56,723,611
|
|
G |
Ash1l |
ASH1 like histone lysine methyltransferase |
decreases expression |
EXP |
Diuron results in decreased expression of ASH1L mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:188,252,592...188,389,251
Ensembl chr 2:188,253,220...188,389,250
|
|
G |
Ash2l |
ASH2 like histone lysine methyltransferase complex subunit |
increases expression |
EXP |
Diuron results in increased expression of ASH2L mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:71,011,315...71,033,171
Ensembl chr16:71,011,332...71,032,790
|
|
G |
Aspn |
asporin |
decreases expression |
EXP |
Diuron results in decreased expression of ASPN mRNA |
CTD |
PMID:25152437 |
|
NCBI chr17:14,655,958...14,681,355
Ensembl chr17:14,656,009...14,679,409
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of ASS1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 3:10,327,411...10,375,847
Ensembl chr 3:10,327,414...10,375,826
|
|
G |
Atf3 |
activating transcription factor 3 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of ATF3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
|
|
G |
Atl3 |
atlastin GTPase 3 |
increases expression |
EXP |
Diuron results in increased expression of ATL3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:222,746,023...222,788,439
Ensembl chr 1:222,746,023...222,786,942
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
increases expression |
EXP |
Diuron results in increased expression of ATOX1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:40,790,850...40,805,886
Ensembl chr10:40,790,845...40,805,941
|
|
G |
Atp10d |
ATPase phospholipid transporting 10D (putative) |
increases expression |
EXP |
Diuron results in increased expression of ATP10D mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:38,475,956...38,575,937
Ensembl chr14:38,477,330...38,575,785
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ATP1A2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:90,651,682...90,676,629
Ensembl chr13:90,651,686...90,676,629
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:82,737,161...82,757,681
Ensembl chr13:82,737,159...82,758,004
|
|
G |
Atp1b3 |
ATPase Na+/K+ transporting subunit beta 3 |
increases expression |
EXP |
Diuron results in increased expression of ATP1B3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:104,190,032...104,221,342
Ensembl chr 8:104,190,032...104,221,342
|
|
G |
Atp23 |
ATP23 metallopeptidase and ATP synthase assembly factor homolog |
decreases expression |
EXP |
Diuron results in decreased expression of ATP23 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:70,183,625...70,198,655
Ensembl chr 7:70,183,625...70,198,655
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression |
EXP |
Diuron results in increased expression of ATP2A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:39,553,903...39,603,326
Ensembl chr12:39,553,903...39,603,326
|
|
G |
Atp2b1 |
ATPase plasma membrane Ca2+ transporting 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:41,114,606...41,223,138
Ensembl chr 7:41,114,697...41,220,579
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
decreases expression |
EXP |
Diuron results in decreased expression of ATP5F1B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:2,504,708...2,511,748
Ensembl chr 7:2,504,695...2,511,749
|
|
G |
Atp5f1e |
ATP synthase F1 subunit epsilon |
decreases expression |
EXP |
Diuron results in decreased expression of ATP5F1E mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:172,563,105...172,566,007
Ensembl chr 3:172,563,105...172,566,010
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ATP6V0D2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 5:33,843,591...33,892,446
Ensembl chr 5:33,843,519...33,892,462
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
increases expression |
EXP |
Diuron results in increased expression of ATP6V1C2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:42,585,452...42,632,289
Ensembl chr 6:42,585,934...42,630,983
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
decreases expression |
EXP |
Diuron results in decreased expression of ATP8B1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:60,013,388...60,152,920
Ensembl chr18:60,013,382...60,095,354
|
|
G |
Atrx |
ATRX, chromatin remodeler |
decreases expression |
EXP |
Diuron results in decreased expression of ATRX mRNA |
CTD |
PMID:25152437 |
|
NCBI chr X:76,820,110...76,979,155
Ensembl chr X:76,692,970...76,708,878 Ensembl chr X:76,692,970...76,708,878
|
|
G |
Atxn10 |
ataxin 10 |
increases expression |
EXP |
Diuron results in increased expression of ATXN10 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:126,228,416...126,351,728
Ensembl chr 7:126,228,295...126,351,634
|
|
G |
Auh |
AU RNA binding methylglutaconyl-CoA hydratase |
increases expression |
EXP |
Diuron results in increased expression of AUH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:12,310,178...12,405,224
Ensembl chr17:12,310,214...12,405,205
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
ISO EXP |
Diuron metabolite results in decreased expression of AXL mRNA Diuron results in decreased expression of AXL mRNA |
CTD |
PMID:24172598 PMID:25152437 |
|
NCBI chr 1:82,550,892...82,580,761
Ensembl chr 1:82,549,420...82,580,761
|
|
G |
B2m |
beta-2 microglobulin |
decreases expression |
EXP |
Diuron results in decreased expression of B2M mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:114,087,287...114,093,311
Ensembl chr 3:114,087,287...114,093,309
|
|
G |
B3galnt1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
decreases expression |
EXP |
Diuron results in decreased expression of B3GALNT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:166,226,736...166,255,978
Ensembl chr 2:166,226,754...166,255,302
|
|
G |
B4galt6 |
beta-1,4-galactosyltransferase 6 |
increases expression |
EXP |
Diuron results in increased expression of B4GALT6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:15,462,913...15,525,584
Ensembl chr18:15,462,913...15,525,579
|
|
G |
Bag1 |
BAG cochaperone 1 |
increases expression |
EXP |
Diuron results in increased expression of BAG1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:57,254,421...57,267,002
Ensembl chr 5:57,254,421...57,267,002
|
|
G |
Baz1a |
bromodomain adjacent to zinc finger domain, 1A |
increases expression |
EXP |
Diuron results in increased expression of BAZ1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:75,793,223...75,873,854
Ensembl chr 6:75,793,960...75,874,235
|
|
G |
Bcl11a |
BAF chromatin remodeling complex subunit BCL11A |
decreases expression |
EXP |
Diuron results in decreased expression of BCL11A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:108,826,717...108,921,197
Ensembl chr14:108,826,831...108,921,669
|
|
G |
Bex3 |
brain expressed X-linked 3 |
increases expression |
EXP |
Diuron results in increased expression of BEX3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr X:106,823,442...106,825,016
Ensembl chr X:106,823,491...106,825,014
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
decreases expression |
EXP |
Diuron results in decreased expression of BHLHE41 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:180,230,742...180,235,138
Ensembl chr 4:180,232,382...180,234,804
|
|
G |
Bicdl1 |
BICD family like cargo adaptor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of BICDL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:46,615,597...46,703,287
Ensembl chr12:46,615,649...46,703,287
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
EXP |
Diuron results in increased expression of BIK mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:124,390,924...124,410,449
Ensembl chr 7:124,391,432...124,410,447
|
|
G |
Bin2 |
bridging integrator 2 |
increases expression |
EXP |
Diuron results in increased expression of BIN2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:142,273,832...142,304,731
Ensembl chr 7:142,273,833...142,300,382
|
|
G |
Blnk |
B-cell linker |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of BLNK mRNA Diuron results in increased expression of BLNK mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:260,187,023...260,254,490
Ensembl chr 1:260,186,967...260,254,600
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
decreases expression increases expression |
EXP ISO |
Diuron results in decreased expression of BMP6 mRNA Diuron metabolite results in increased expression of BMP6 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr17:26,955,142...27,112,820
Ensembl chr17:26,955,142...27,112,820
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
decreases expression |
EXP |
Diuron results in decreased expression of BMPR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:66,568,074...66,683,019
Ensembl chr 9:66,568,074...66,676,494
|
|
G |
Bnc1 |
basonuclin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of BNC1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:143,793,280...143,818,748 NCBI chr 1:143,869,440...143,878,077
Ensembl chr 1:143,793,064...143,818,706
|
|
G |
Bnc2 |
basonuclin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of BNC2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:102,407,508...102,807,389
Ensembl chr 5:102,415,847...102,786,331
|
|
G |
Bok |
BCL2 family apoptosis regulator BOK |
increases expression |
EXP |
Diuron results in increased expression of BOK mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:100,829,593...100,840,498
Ensembl chr 9:100,829,552...100,840,504
|
|
G |
Bphl |
biphenyl hydrolase like |
decreases expression |
EXP |
Diuron results in decreased expression of BPHL mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:31,498,877...31,535,172
Ensembl chr17:31,498,883...31,535,172
|
|
G |
Bptf |
bromodomain PHD finger transcription factor |
decreases expression |
EXP |
Diuron results in decreased expression of BPTF mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr10:95,248,573...95,350,162
Ensembl chr10:95,250,294...95,349,789
|
|
G |
Brd4 |
bromodomain containing 4 |
decreases expression |
EXP |
Diuron results in decreased expression of BRD4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:14,222,101...14,303,055
Ensembl chr 7:14,222,101...14,303,055
|
|
G |
Brf2 |
BRF2, RNA polymerase III transcription initiation factor subunit |
increases expression |
EXP |
Diuron results in increased expression of BRF2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:69,089,955...69,094,678
Ensembl chr16:69,089,955...69,094,680
|
|
G |
Brinp1 |
BMP/retinoic acid inducible neural specific 1 |
increases expression |
EXP |
Diuron results in increased expression of BRINP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:84,919,416...85,123,828
Ensembl chr 5:84,919,367...85,123,829
|
|
G |
Bsg |
basigin (Ok blood group) |
decreases expression |
EXP |
Diuron results in decreased expression of BSG mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:12,875,536...12,882,753
Ensembl chr 7:12,875,537...12,882,753
|
|
G |
Bspry |
B-box and SPRY domain containing |
decreases expression |
EXP |
Diuron results in decreased expression of BSPRY mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:78,334,284...78,356,462
Ensembl chr 5:78,334,284...78,356,460
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
EXP |
Diuron results in decreased expression of BST2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:19,938,781...19,942,353
Ensembl chr16:19,938,784...19,942,353
|
|
G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
increases expression |
EXP |
Diuron results in increased expression of BZW1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:65,279,675...65,293,471
Ensembl chr 9:65,279,675...65,291,651
|
|
G |
C1qa |
complement C1q A chain |
decreases expression |
EXP |
Diuron results in decreased expression of C1QA mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:155,261,254...155,264,101
Ensembl chr 5:155,261,250...155,264,143
|
|
G |
C1qb |
complement C1q B chain |
decreases expression |
EXP |
Diuron results in decreased expression of C1QB mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:155,246,444...155,251,995
Ensembl chr 5:155,246,447...155,252,003
|
|
G |
C1qbp |
complement C1q binding protein |
increases expression |
EXP |
Diuron results in increased expression of C1QBP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:57,613,876...57,618,527
Ensembl chr10:57,613,879...57,618,527
|
|
G |
C1qc |
complement C1q C chain |
decreases expression |
EXP |
Diuron results in decreased expression of C1QC mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:155,255,013...155,258,631
Ensembl chr 5:155,255,005...155,258,392
|
|
G |
C1qtnf2 |
C1q and TNF related 2 |
decreases expression |
EXP |
Diuron results in decreased expression of C1QTNF2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:29,067,102...29,084,035
Ensembl chr10:29,067,102...29,084,035
|
|
G |
C1qtnf6 |
C1q and TNF related 6 |
decreases expression |
EXP |
Diuron results in decreased expression of C1QTNF6 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:119,746,150...119,752,727
Ensembl chr 7:119,746,118...119,753,290
|
|
G |
C1r |
complement C1r |
decreases expression |
EXP |
Diuron results in decreased expression of C1R mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:157,126,060...157,136,825
Ensembl chr 4:157,125,998...157,136,829
|
|
G |
C1s |
complement C1s |
decreases expression |
EXP |
Diuron results in decreased expression of C1S mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:157,143,592...157,155,592
Ensembl chr 4:157,143,592...157,155,609
|
|
G |
C2 |
complement C2 |
decreases expression |
EXP |
Diuron results in decreased expression of C2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr20:4,542,340...4,561,152
Ensembl chr20:4,542,340...4,561,152
|
|
G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
decreases expression |
EXP |
Diuron results in decreased expression of C2CD2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:38,354,746...38,420,133
Ensembl chr11:38,357,424...38,420,119
|
|
G |
C2cd2l |
C2CD2-like |
decreases expression |
EXP |
Diuron results in decreased expression of C2CD2L mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:48,641,792...48,652,119
Ensembl chr 8:48,641,801...48,652,071
|
|
G |
C3 |
complement C3 |
increases expression |
ISO EXP |
Diuron metabolite results in increased expression of C3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
C4b |
complement C4B (Chido blood group) |
decreases expression |
EXP |
Diuron results in decreased expression of C4B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:4,302,344...4,316,752
Ensembl chr20:4,302,344...4,316,715
|
|
G |
C7 |
complement C7 |
decreases expression |
EXP |
Diuron results in decreased expression of C7 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:54,707,621...54,781,624
Ensembl chr 2:54,709,138...54,777,729
|
|
G |
Ca12 |
carbonic anhydrase 12 |
increases expression |
EXP |
Diuron results in increased expression of CAR12 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:72,405,770...72,461,425
Ensembl chr 8:72,405,748...72,460,240
|
|
G |
Ca3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CAR3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
|
|
G |
Ca5b |
carbonic anhydrase 5B |
increases expression |
EXP |
Diuron results in increased expression of CA5B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:32,232,106...32,291,124
Ensembl chr X:32,232,142...32,292,072
|
|
G |
Ca8 |
carbonic anhydrase 8 |
decreases expression |
EXP |
Diuron results in decreased expression of CAR8 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:21,249,018...21,345,810
Ensembl chr 5:21,249,020...21,345,810
|
|
G |
Caap1 |
caspase activity and apoptosis inhibitor 1 |
increases expression |
EXP |
Diuron results in increased expression of CAAP1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:113,479,416...113,532,961
Ensembl chr 5:113,480,547...113,532,878
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
increases expression |
EXP |
Diuron results in increased expression of CADM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:51,858,906...52,200,591
Ensembl chr 8:52,127,399...52,189,722
|
|
G |
Cadm3 |
cell adhesion molecule 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CADM3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:91,842,311...91,873,126
Ensembl chr13:91,842,333...91,873,096
|
|
G |
Cald1 |
caldesmon 1 |
increases expression |
EXP |
Diuron results in increased expression of CALD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:62,103,948...62,291,375
Ensembl chr 4:62,220,736...62,291,489
|
|
G |
Calm1 |
calmodulin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CALM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:124,217,241...124,225,292
Ensembl chr 6:124,217,241...124,225,292
|
|
G |
Calm2 |
calmodulin 2 |
increases expression |
EXP |
Diuron results in increased expression of CALM2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:11,067,675...11,080,078
Ensembl chr15:65,506,874...65,507,968
|
|
G |
Calml3 |
calmodulin-like 3 |
increases expression |
EXP |
Diuron results in increased expression of CALML3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:70,070,458...70,073,697
Ensembl chr17:70,072,156...70,073,530
|
|
G |
Calml4 |
calmodulin-like 4 |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of CALML4 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:67,753,279...67,765,359
Ensembl chr 8:67,753,279...67,765,358
|
|
G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
decreases expression |
EXP |
Diuron results in decreased expression of CAMK2D mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:230,900,907...231,132,207
Ensembl chr 2:230,901,126...231,132,039
|
|
G |
Canx |
calnexin |
decreases expression |
EXP |
Diuron results in decreased expression of CANX mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
|
|
G |
Capg |
capping actin protein, gelsolin like |
decreases expression |
EXP |
Diuron results in decreased expression of CAPG mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:100,395,693...100,419,447
Ensembl chr 4:100,407,658...100,419,446
|
|
G |
Capn2 |
calpain 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CAPN2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:100,878,649...100,928,811
Ensembl chr13:100,878,650...100,928,811
|
|
G |
Capn9 |
calpain 9 |
increases expression |
EXP |
Diuron results in increased expression of CAPN9 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:57,341,938...57,378,901
Ensembl chr19:57,341,938...57,378,901
|
|
G |
Caprin1 |
cell cycle associated protein 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CAPRIN1 mRNA Diuron results in decreased expression of CAPRIN1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 3:93,701,830...93,789,580
Ensembl chr 3:93,702,487...93,789,617
|
|
G |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
increases expression |
EXP |
Diuron results in increased expression of CARMIL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:43,050,282...43,339,403
Ensembl chr17:43,050,789...43,339,403
|
|
G |
Casq1 |
calsequestrin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CASQ1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:90,592,676...90,602,365
Ensembl chr13:90,592,681...90,602,365
|
|
G |
Cast |
calpastatin |
decreases expression |
EXP |
Diuron results in decreased expression of CAST mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:1,452,111...1,561,669
Ensembl chr 2:1,452,116...1,561,464
|
|
G |
Cat |
catalase |
decreases expression |
EXP |
Diuron results in decreased expression of CAT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cav1 |
caveolin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CAV1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Cav2 |
caveolin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CAV2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:44,573,264...44,580,640
Ensembl chr 4:44,573,264...44,580,638
|
|
G |
Cavin2 |
caveolae associated protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CAVIN2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:55,244,136...55,256,153
Ensembl chr 9:55,243,255...55,256,340
|
|
G |
Cavin3 |
caveolae associated protein 3 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CAVIN3 mRNA Diuron results in decreased expression of CAVIN3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:170,317,099...170,318,688
Ensembl chr 1:170,317,113...170,318,935
|
|
G |
Cbl |
Cbl proto-oncogene |
decreases expression |
EXP |
Diuron results in decreased expression of CBL mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:48,481,256...48,564,775
Ensembl chr 8:48,489,036...48,564,722
|
|
G |
Cblb |
Cbl proto-oncogene B |
increases expression |
EXP |
Diuron results in increased expression of CBLB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:51,037,383...51,202,761
Ensembl chr11:51,037,393...51,202,820
|
|
G |
Cbr1 |
carbonyl reductase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CBR1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:33,813,041...33,815,418
Ensembl chr11:33,845,463...33,847,793
|
|
G |
Cbr3 |
carbonyl reductase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CBR3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:33,909,417...33,917,674
Ensembl chr11:33,909,439...33,917,674
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CCDC113 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr19:9,912,124...9,932,183
Ensembl chr19:9,912,183...9,931,930
|
|
G |
Ccdc152 |
coiled-coil domain containing 152 |
decreases expression |
EXP |
Diuron results in decreased expression of CCDC152 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:53,116,105...53,140,661
Ensembl chr 2:53,116,101...53,140,637
|
|
G |
Ccdc62 |
coiled-coil domain containing 62 |
decreases expression |
EXP |
Diuron results in decreased expression of CCDC62 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:38,057,532...38,093,916
Ensembl chr12:38,057,556...38,093,050
|
|
G |
Ccdc69 |
coiled-coil domain containing 69 |
increases expression |
EXP |
Diuron results in increased expression of CCDC69 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:40,392,459...40,419,567
Ensembl chr10:40,392,460...40,419,054
|
|
G |
Ccdc77 |
coiled-coil domain containing 77 |
increases expression |
EXP |
Diuron results in increased expression of CCDC77 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:152,860,669...152,892,518
Ensembl chr 4:152,860,675...152,883,210
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
decreases expression |
EXP |
Diuron results in decreased expression of CCDC80 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr11:60,645,660...60,679,249
Ensembl chr11:60,645,086...60,679,555
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
decreases expression |
EXP |
Diuron results in decreased expression of CCL11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
|
|
G |
Ccl21 |
C-C motif chemokine ligand 21 |
increases expression |
EXP |
Diuron results in increased expression of CCL21 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:58,197,678...58,198,782
Ensembl chr 5:58,197,680...58,198,782
|
|
G |
Ccl6 |
C-C motif chemokine ligand 6 |
decreases expression |
EXP |
Diuron results in decreased expression of CCL6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:70,798,118...70,802,750
Ensembl chr10:70,797,124...70,802,782
|
|
G |
Ccn1 |
cellular communication network factor 1 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CCN1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:251,529,354...251,532,312
Ensembl chr 2:251,529,354...251,532,312
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression decreases expression |
EXP ISO |
Diuron results in increased expression of CCN2 mRNA Diuron metabolite results in decreased expression of CCN2 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
|
|
G |
Ccn3 |
cellular communication network factor 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CCN3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 7:94,375,134...94,382,154
Ensembl chr 7:94,375,020...94,383,024
|
|
G |
Ccndbp1 |
cyclin D1 binding protein 1 |
increases expression |
EXP |
Diuron results in increased expression of CCNDBP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:112,951,065...112,961,620
Ensembl chr 3:112,950,890...112,961,614
|
|
G |
Ccni |
cyclin I |
decreases expression |
EXP |
Diuron results in decreased expression of CCNI mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:16,341,510...16,364,326
Ensembl chr14:16,341,536...16,364,326
|
|
G |
Ccnl2 |
cyclin L2 |
decreases expression |
EXP |
Diuron results in decreased expression of CCNL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:173,256,301...173,268,279
Ensembl chr 5:173,256,637...173,276,169
|
|
G |
Ccpg1 |
cell cycle progression 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CCPG1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:79,660,634...79,692,044
Ensembl chr 8:79,660,657...79,692,039
|
|
G |
Cd163 |
CD163 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD163 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:156,752,063...156,785,467
Ensembl chr 4:156,752,082...156,785,467
|
|
G |
Cd164 |
CD164 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD164 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:46,250,418...46,261,994
Ensembl chr20:46,250,363...46,261,994
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD24 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:48,335,540...48,340,847
Ensembl chr20:48,335,540...48,340,846
|
|
G |
Cd248 |
CD248 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD248 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:220,353,308...220,355,872
Ensembl chr 1:220,446,425...220,448,989
|
|
G |
Cd302 |
CD302 molecule |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CD302 mRNA Diuron results in decreased expression of CD302 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 3:46,327,382...46,361,092
Ensembl chr 3:46,327,383...46,361,092
|
|
G |
Cd34 |
CD34 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD34 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:113,691,842...113,711,259
Ensembl chr13:113,691,932...113,711,647
|
|
G |
Cd36 |
CD36 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD36 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cd3g |
CD3g molecule |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of CD3G mRNA Diuron results in increased expression of CD3G mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 8:49,274,553...49,280,943
Ensembl chr 8:49,274,960...49,280,901
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
increases expression |
EXP |
Diuron results in increased expression of CD44 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cd48 |
Cd48 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD48 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:90,116,601...90,140,371
Ensembl chr13:90,116,843...90,140,371
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
decreases expression |
EXP |
Diuron results in decreased expression of CD55 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
|
|
G |
Cd59 |
CD59 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD59 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:94,010,481...94,028,660
Ensembl chr 3:94,010,475...94,028,621
|
|
G |
Cd63 |
Cd63 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD63 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:3,320,250...3,335,583
Ensembl chr 7:3,320,103...3,335,582
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD74 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:56,071,420...56,080,851
Ensembl chr18:56,071,478...56,080,849
|
|
G |
Cd86 |
CD86 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD86 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
|
|
G |
Cd9 |
CD9 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD9 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:157,977,163...158,010,091
Ensembl chr 4:157,977,162...158,010,166
|
|
G |
Cd93 |
CD93 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD93 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:142,778,798...142,783,774
Ensembl chr 3:142,778,770...142,783,774
|
|
G |
Cdc42ep2 |
CDC42 effector protein 2 |
increases expression |
EXP |
Diuron results in increased expression of CDC42EP2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:221,272,349...221,281,252
Ensembl chr 1:221,272,353...221,281,180
|
|
G |
Cdc42ep4 |
CDC42 effector protein 4 |
increases expression |
EXP |
Diuron results in increased expression of CDC42EP4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:102,244,680...102,269,272
Ensembl chr10:102,244,681...102,269,272
|
|
G |
Cdc42se2 |
CDC42 small effector 2 |
increases expression |
EXP |
Diuron results in increased expression of CDC42SE2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:40,054,393...40,122,915
Ensembl chr10:40,054,400...40,122,915
|
|
G |
Cdca7 |
cell division cycle associated 7 |
increases expression |
EXP |
Diuron results in increased expression of CDCA7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:59,153,281...59,163,916
Ensembl chr 3:59,153,280...59,163,913
|
|
G |
Cdcp1 |
CUB domain containing protein 1 |
increases expression |
ISO |
Diuron metabolite results in increased expression of CDCP1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:132,260,007...132,296,661
Ensembl chr 8:132,260,029...132,296,661
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
EXP |
Diuron results in decreased expression of CDH11 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:2,391,181...2,551,245
Ensembl chr19:2,393,059...2,551,245
|
|
G |
Cdh22 |
cadherin 22 |
decreases expression |
EXP |
Diuron results in decreased expression of CDH22 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:161,574,993...161,971,102
Ensembl chr 3:161,575,631...161,917,285
|
|
G |
Cdh5 |
cadherin 5 |
increases expression |
EXP |
Diuron results in increased expression of CDH5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:1,025,122...1,074,333
Ensembl chr19:1,023,683...1,074,365
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
EXP |
Diuron results in increased expression of CDK1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
increases expression |
EXP |
Diuron results in increased expression of CDKN1C mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:216,661,067...216,663,791
Ensembl chr 1:216,661,080...216,663,721
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CDO1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:40,702,027...40,716,901
Ensembl chr18:40,701,984...40,716,686
|
|
G |
Cdpf1 |
cysteine rich, DPF motif domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of CDPF1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:126,687,404...126,692,783
Ensembl chr 7:126,687,405...126,691,232
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
increases expression |
ISO |
Diuron metabolite results in increased expression of CEACAM1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 1:82,327,955...82,344,345
Ensembl chr 1:82,327,955...82,344,345
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
EXP |
Diuron results in increased expression of CEBPG mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:91,286,956...91,297,459
Ensembl chr 1:91,287,917...91,296,656
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CELF2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:75,259,269...75,660,154
Ensembl chr17:75,352,389...75,654,951
|
|
G |
Cep126 |
centrosomal protein 126 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CEP126 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:6,237,838...6,305,127
Ensembl chr 8:6,255,850...6,305,033
|
|
G |
Cercam |
cerebral endothelial cell adhesion molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CERCAM mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:8,421,116...8,444,743
Ensembl chr 3:8,430,829...8,444,851
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CES1D mRNA Diuron results in decreased expression of CES1D mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
|
|
G |
Ces5a |
carboxylesterase 5A |
decreases expression |
EXP |
Diuron results in decreased expression of CES5A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:12,097,529...12,136,579
Ensembl chr19:12,097,632...12,136,240
|
|
G |
Cesl1 |
carboxylesterase-like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CESL1 mRNA |
CTD |
PMID:21551480 |
|
Ensembl chr19:15,081,158...15,335,002
|
|
G |
Cfap20dc |
CFAP20 domain containing |
increases expression |
ISO |
Diuron metabolite results in increased expression of CFAP20DC mRNA |
CTD |
PMID:24172598 |
|
NCBI chr15:17,664,838...17,918,216
Ensembl chr15:17,775,692...17,924,302
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CFAP300 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:6,218,391...6,236,438
Ensembl chr 8:6,218,393...6,235,967
|
|
G |
Cfb |
complement factor B |
decreases expression |
EXP |
Diuron results in decreased expression of CFB mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr20:4,536,206...4,542,073
Ensembl chr20:4,536,203...4,561,066 Ensembl chr20:4,536,203...4,561,066
|
|
G |
Cfd |
complement factor D |
decreases expression |
EXP |
Diuron results in decreased expression of CFD mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:12,634,216...12,635,939
Ensembl chr 7:12,634,216...12,635,943
|
|
G |
Cfh |
complement factor H |
decreases expression |
EXP |
Diuron results in decreased expression of CFH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
|
|
G |
Cfl2 |
cofilin 2 |
increases expression |
EXP |
Diuron results in increased expression of CFL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:75,759,140...75,763,185
Ensembl chr 6:75,759,140...75,763,185
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
EXP |
Diuron results in increased expression of CFLAR mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:65,534,608...65,586,395
Ensembl chr 9:65,534,704...65,587,251
|
|
G |
Cgnl1 |
cingulin-like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CGNL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:78,126,670...78,278,490
Ensembl chr 8:78,126,675...78,233,430
|
|
G |
Chd2 |
chromodomain helicase DNA binding protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CHD2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:134,757,934...134,873,053
Ensembl chr 1:134,757,934...134,871,167
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
decreases expression |
EXP |
Diuron results in decreased expression of CHD4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:157,612,531...157,645,660
Ensembl chr 4:157,612,536...157,645,659
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases expression |
EXP |
Diuron results in increased expression of CHEK2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:51,845,574...51,878,098
Ensembl chr12:51,845,796...51,877,624
|
|
G |
Chmp2a |
charged multivesicular body protein 2A |
increases expression |
EXP |
Diuron results in increased expression of CHMP2A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:65,540,808...65,543,708
Ensembl chr 1:65,541,322...65,543,707
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of CHORDC1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:17,421,552...17,445,513
Ensembl chr 8:17,421,557...17,446,165
|
|
G |
Chp1 |
calcineurin-like EF-hand protein 1 |
increases expression |
EXP |
Diuron results in increased expression of CHP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:111,354,506...111,389,998
Ensembl chr 3:111,354,506...111,389,989
|
|
G |
Chpf |
chondroitin polymerizing factor |
decreases expression |
EXP |
Diuron results in decreased expression of CHPF mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:82,669,199...82,673,898
Ensembl chr 9:82,669,204...82,673,898
|
|
G |
Chrnb1 |
cholinergic receptor nicotinic beta 1 subunit |
increases expression |
EXP |
Diuron results in increased expression of CHRNB1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:56,390,671...56,403,255
Ensembl chr10:56,390,671...56,403,188
|
|
G |
Churc1 |
churchill domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of CHURC1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:99,817,439...99,831,574
Ensembl chr 6:99,817,431...99,831,576
|
|
G |
Cib2 |
calcium and integrin binding family member 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CIB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:59,123,078...59,139,946
Ensembl chr 8:59,123,079...59,139,946
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
decreases expression |
EXP |
Diuron results in decreased expression of CIDEA mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:63,082,861...63,108,450
Ensembl chr18:63,098,144...63,108,051
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
decreases expression |
EXP |
Diuron results in decreased expression of CIDEC mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:145,377,482...145,390,497
Ensembl chr 4:145,377,431...145,390,497
|
|
G |
Cilk1 |
ciliogenesis associated kinase 1 |
increases expression |
EXP |
Diuron results in increased expression of CILK1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:85,413,998...85,473,374
Ensembl chr 8:85,413,537...85,472,694
|
|
G |
Cisd3 |
CDGSH iron sulfur domain 3 |
increases expression |
EXP |
Diuron results in increased expression of CISD3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:85,628,579...85,631,656
Ensembl chr10:85,628,491...85,631,657
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CITED2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:12,823,363...12,825,806
Ensembl chr 1:12,823,363...12,825,786
|
|
G |
Ckm |
creatine kinase, M-type |
decreases expression |
EXP |
Diuron results in decreased expression of CKM mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:80,321,507...80,331,841
Ensembl chr 1:80,321,585...80,331,841
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CLDN1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:77,815,216...77,830,373
Ensembl chr11:77,815,181...77,830,416
|
|
G |
Cldn11 |
claudin 11 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CLDN11 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:115,823,541...115,836,846
Ensembl chr 2:115,823,538...115,836,846
|
|
G |
Clec10a |
C-type lectin domain containing 10A |
decreases expression |
EXP |
Diuron results in decreased expression of CLEC10A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:56,764,927...56,769,447
Ensembl chr10:56,764,927...56,769,457
|
|
G |
Clec11a |
C-type lectin domain containing 11A |
increases expression |
EXP |
Diuron results in increased expression of CLEC11A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:100,290,374...100,293,515
Ensembl chr 1:100,289,295...100,293,558
|
|
G |
Clgn |
calmegin |
increases expression |
ISO |
Diuron metabolite results in increased expression of CLGN mRNA |
CTD |
PMID:24172598 |
|
NCBI chr19:24,545,257...24,578,527
Ensembl chr19:24,545,318...24,576,798
|
|
G |
Clic2 |
chloride intracellular channel 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CLIC2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:295,338...310,363
Ensembl chr20:295,250...310,380
|
|
G |
Clic3 |
chloride intracellular channel 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CLIC3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:2,675,732...2,678,248
Ensembl chr 3:2,676,296...2,680,565
|
|
G |
Clic4 |
chloride intracellular channel 4 |
decreases expression |
EXP |
Diuron results in decreased expression of CLIC4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:153,568,937...153,625,669
Ensembl chr 5:153,568,745...153,625,869
|
|
G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CLIP1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr12:38,345,203...38,452,650
Ensembl chr12:38,345,456...38,452,652
|
|
G |
Clmp |
CXADR-like membrane protein |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CLMP mRNA Diuron results in decreased expression of CLMP mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 8:44,846,685...44,975,460
Ensembl chr 8:44,847,157...44,975,457
|
|
G |
Cln5 |
CLN5, intracellular trafficking protein |
increases expression |
EXP |
Diuron results in increased expression of CLN5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:93,634,815...93,644,146
|
|
G |
Cmas |
cytidine monophosphate N-acetylneuraminic acid synthetase |
decreases expression |
EXP |
Diuron results in decreased expression of CMAS mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:176,994,129...177,012,445
Ensembl chr 4:176,994,129...177,012,444
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CMPK2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:45,683,242...45,694,824
Ensembl chr 6:45,683,234...45,694,822
|
|
G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CMTM3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:830,874...838,528
Ensembl chr19:830,877...838,099
|
|
G |
Cmtm7 |
CKLF-like MARVEL transmembrane domain containing 7 |
decreases expression |
EXP |
Diuron results in decreased expression of CMTM7 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:122,814,563...122,841,479
Ensembl chr 8:122,812,459...122,841,477
|
|
G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
decreases expression |
EXP |
Diuron results in decreased expression of CMTM8 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:122,848,249...122,913,597
Ensembl chr 8:122,848,501...122,904,913
|
|
G |
Cmtr1 |
cap methyltransferase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CMTR1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:8,324,968...8,385,174
Ensembl chr20:8,312,792...8,368,764
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CNDP1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr18:81,466,717...81,512,841
Ensembl chr18:81,466,716...81,499,051
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CNDP2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:81,521,966...81,539,065
Ensembl chr18:81,521,968...81,539,065
|
|
G |
Cnn1 |
calponin 1 |
increases expression |
EXP |
Diuron results in increased expression of CNN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:23,113,083...23,121,748
Ensembl chr 8:23,113,048...23,121,761
|
|
G |
Cnn3 |
calponin 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CNN3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:225,005,069...225,036,179
Ensembl chr 2:225,005,019...225,036,188
|
|
G |
Cobl |
cordon-bleu WH2 repeat protein |
decreases expression |
EXP |
Diuron results in decreased expression of COBL mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:92,341,949...92,497,169
Ensembl chr14:92,342,957...92,577,936
|
|
G |
Col11a2 |
collagen type XI alpha 2 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL11A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:3,829,324...3,859,022
Ensembl chr20:3,830,164...3,859,018
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
increases expression |
EXP |
Diuron results in increased expression of COL12A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:87,042,820...87,150,701
Ensembl chr 8:87,040,799...87,158,368
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL14A1 mRNA Diuron results in decreased expression of COL14A1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 7:95,054,877...95,274,073
Ensembl chr 7:95,074,236...95,273,298
|
|
G |
Col15a1 |
collagen type XV alpha 1 chain |
increases expression |
EXP |
Diuron results in increased expression of COL15A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:62,840,360...62,950,240
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL1A1 mRNA Diuron results in decreased expression of COL1A1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL1A2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:31,534,225...31,569,152
Ensembl chr 4:31,534,225...31,569,151
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL3A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
increases expression |
EXP |
Diuron results in increased expression of COL4A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:83,522,162...83,632,153
Ensembl chr16:83,522,162...83,632,153
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
increases expression |
EXP |
Diuron results in increased expression of COL4A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:83,386,388...83,522,169
Ensembl chr16:83,387,364...83,438,561
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL5A1 mRNA Diuron results in decreased expression of COL5A1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL5A2 mRNA Diuron results in decreased expression of COL5A2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 9:52,091,088...52,238,735
Ensembl chr 9:52,092,511...52,238,564
|
|
G |
Col5a3 |
collagen type V alpha 3 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL5A3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:21,786,324...21,831,751
Ensembl chr 8:21,786,324...21,831,668
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL6A1 mRNA Diuron results in decreased expression of COL6A1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr20:12,657,913...12,676,370
Ensembl chr20:12,658,065...12,675,561
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL6A2 mRNA Diuron results in decreased expression of COL6A2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr20:12,773,472...12,801,179
Ensembl chr20:12,773,427...12,801,180
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
increases expression |
EXP |
Diuron results in increased expression of COL6A3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:97,926,784...98,004,643
Ensembl chr 9:97,926,787...98,004,546
|
|
G |
Col6a6 |
collagen type VI alpha 6 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL6A6 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:114,352,130...114,449,993
Ensembl chr 8:114,353,825...114,449,956
|
|
G |
Col7a1 |
collagen type VII alpha 1 chain |
increases expression |
EXP |
Diuron results in increased expression of COL7A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:117,694,441...117,726,844
Ensembl chr 8:117,694,605...117,726,844
|
|
G |
Colgalt1 |
collagen beta(1-O)galactosyltransferase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of COLGALT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:20,039,969...20,052,277
Ensembl chr16:20,039,969...20,052,276
|
|
G |
Comt |
catechol-O-methyltransferase |
decreases expression |
EXP |
Diuron results in decreased expression of COMT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Copg2 |
COPI coat complex subunit gamma 2 |
decreases expression |
EXP |
Diuron results in decreased expression of COPG2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:58,064,394...58,195,242
Ensembl chr 4:58,064,833...58,195,143
|
|
G |
Coq10b |
coenzyme Q10B |
increases expression |
EXP |
Diuron results in increased expression of COQ10B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:61,655,963...61,675,880
Ensembl chr 9:61,655,963...61,675,873
|
|
G |
Coq3 |
coenzyme Q3 methyltransferase |
increases expression |
EXP |
Diuron results in increased expression of COQ3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:36,024,673...36,056,664
Ensembl chr 5:36,024,649...36,056,669
|
|
G |
Coq6 |
coenzyme Q6 monooxygenase |
increases expression |
EXP |
Diuron results in increased expression of COQ6 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 6:108,076,393...108,087,782
Ensembl chr 6:108,076,306...108,087,696
|
|
G |
Coro6 |
coronin 6 |
increases expression |
EXP |
Diuron results in increased expression of CORO6 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:62,691,952...62,700,658
Ensembl chr10:62,691,953...62,699,723
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
increases expression |
EXP |
Diuron results in increased expression of COX5A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:62,298,358...62,309,765
Ensembl chr 8:62,298,358...62,309,765
|
|
G |
Cp |
ceruloplasmin |
decreases expression |
EXP |
Diuron results in decreased expression of CP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
|
|
G |
Cpe |
carboxypeptidase E |
decreases expression |
EXP |
Diuron results in decreased expression of CPE mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:26,906,716...27,014,811
Ensembl chr16:26,906,716...27,014,813
|
|
G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CPEB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:72,327,929...72,382,519
Ensembl chr14:72,331,705...72,380,330
|
|
G |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
increases expression |
EXP |
Diuron results in increased expression of CPEB4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:15,984,520...16,047,209
Ensembl chr10:15,987,921...16,046,033
|
|
G |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CPED1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:49,055,988...49,333,729
Ensembl chr 4:49,056,010...49,333,304
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
EXP |
Diuron results in decreased expression of PGCP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:71,709,174...72,167,413
Ensembl chr 7:71,709,157...72,167,417
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
increases expression |
EXP |
Diuron results in increased expression of CPT1C mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:100,955,094...100,970,579
Ensembl chr 1:100,955,095...100,969,560
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
EXP |
Diuron results in increased expression of CPT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:127,505,646...127,523,016
Ensembl chr 5:127,505,614...127,523,089
|
|
G |
Cpxm1 |
carboxypeptidase X (M14 family), member 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CPXM1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:122,913,886...122,920,684
Ensembl chr 3:122,913,886...122,920,684
|
|
G |
Cracr2b |
calcium release activated channel regulator 2B |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of CRACR2B mRNA Diuron results in increased expression of CRACR2B mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:214,439,810...214,445,876
Ensembl chr 1:214,440,503...214,445,874
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
EXP |
Diuron results in decreased expression of CREBBP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
|
|
G |
Crebzf |
CREB/ATF bZIP transcription factor |
increases expression |
EXP |
Diuron results in increased expression of CREBZF mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:156,290,215...156,296,891
Ensembl chr 1:156,294,519...156,296,161
|
|
G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
increases expression |
EXP |
Diuron results in increased expression of CRELD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:145,440,284...145,449,894
Ensembl chr 4:145,440,114...145,449,892
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CRELD2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:129,812,746...129,819,641
Ensembl chr 7:129,812,789...129,819,634
|
|
G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CRIM1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:788,490...962,663
Ensembl chr 6:788,548...960,703
|
|
G |
Crip1 |
cysteine rich protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CRIP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:137,959,171...137,967,042
Ensembl chr 6:137,959,171...137,967,042
|
|
G |
Crk |
CRK proto-oncogene, adaptor protein |
increases expression |
EXP |
Diuron results in increased expression of CRK mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:63,829,731...63,855,999
Ensembl chr10:63,829,807...63,852,780
|
|
G |
Crnde |
colorectal neoplasia differentially expressed |
decreases expression |
EXP |
Diuron results in decreased expression of CRNDE mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:16,405,308...16,415,786
|
|
G |
Cryab |
crystallin, alpha B |
increases expression |
EXP |
Diuron results in increased expression of CRYAB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:55,178,543...55,182,546
Ensembl chr 8:55,178,289...55,182,545
|
|
G |
Csf3 |
colony stimulating factor 3 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CSF3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CSGALNACT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:22,704,318...23,075,071
Ensembl chr16:22,979,444...23,074,798
|
|
G |
Csn1s1 |
casein alpha s1 |
decreases expression |
EXP |
Diuron results in decreased expression of CSN1S1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:21,993,450...22,009,308
Ensembl chr14:21,993,427...22,009,308
|
|
G |
Csnk1a1 |
casein kinase 1, alpha 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CSNK1A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:56,887,722...56,910,610
Ensembl chr18:56,887,354...56,918,345
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
EXP |
Diuron results in increased expression of CSRP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:52,553,843...52,575,054
Ensembl chr13:52,553,775...52,575,051
|
|
G |
Cst3 |
cystatin C |
increases expression |
EXP |
Diuron results in increased expression of CST3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:143,219,671...143,223,544
Ensembl chr 3:143,219,686...143,223,615
|
|
G |
Cst6 |
cystatin E/M |
increases expression |
EXP |
Diuron results in increased expression of CST6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:220,727,292...220,729,000
Ensembl chr 1:220,727,292...220,729,000
|
|
G |
Cstb |
cystatin B |
increases expression |
ISO |
Diuron metabolite results in increased expression of CSTB mRNA |
CTD |
PMID:24172598 |
|
NCBI chr20:10,966,357...10,968,399
Ensembl chr20:10,966,331...10,968,432
|
|
G |
Ctnnal1 |
catenin alpha-like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CTNNAL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:73,561,249...73,621,070
Ensembl chr 5:73,561,450...73,621,070
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases expression |
EXP |
Diuron results in increased expression of CTNNB1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Ctps2 |
CTP synthase 2 |
increases expression |
EXP |
Diuron results in increased expression of CTPS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:33,383,087...33,522,852
Ensembl chr X:33,383,087...33,522,836
|
|
G |
Ctsb |
cathepsin B |
decreases expression |
EXP |
Diuron results in decreased expression of CTSB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
|
|
G |
Ctsd |
cathepsin D |
decreases expression |
EXP |
Diuron results in decreased expression of CTSD mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451
|
|
G |
Ctse |
cathepsin E |
increases expression |
EXP |
Diuron metabolite results in increased expression of CTSE mRNA; Diuron results in increased expression of CTSE mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr13:48,426,833...48,449,493
Ensembl chr13:48,426,820...48,449,490
|
|
G |
Ctsk |
cathepsin K |
decreases expression |
EXP |
Diuron results in decreased expression of CTSK mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:196,655,469...196,666,447
Ensembl chr 2:196,655,469...196,666,446
|
|
G |
Ctss |
cathepsin S |
decreases expression |
EXP |
Diuron results in decreased expression of CTSS mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:197,655,780...197,679,768
Ensembl chr 2:197,655,786...197,679,458
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CX3CL1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr19:10,644,267...10,654,861
Ensembl chr19:10,644,244...10,653,800
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CXCL1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression decreases expression |
EXP |
Diuron metabolite results in increased expression of CXCL12 mRNA Diuron results in decreased expression of CXCL12 mRNA |
CTD |
PMID:21551480 PMID:24172598 PMID:25152437 |
|
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
increases expression |
EXP |
Diuron results in increased expression of CXCL14 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:9,109,731...9,117,754
Ensembl chr17:9,109,731...9,117,750
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CXCL2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
decreases expression |
EXP |
Diuron results in decreased expression of CXCL9 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:17,228,832...17,233,743
Ensembl chr14:17,228,856...17,234,712
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
EXP |
Diuron results in increased expression of CXCR4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
|
|
G |
Cxxc5 |
CXXC finger protein 5 |
decreases expression |
EXP |
Diuron results in decreased expression of CXXC5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:28,626,386...28,656,916
Ensembl chr18:28,653,592...28,656,937
|
|
G |
Cyb561 |
cytochrome b-561 |
decreases expression |
EXP |
Diuron results in decreased expression of CYB561 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:94,136,993...94,147,567
Ensembl chr10:94,136,993...94,147,621
|
|
G |
Cygb |
cytoglobin |
decreases expression |
EXP |
Diuron results in decreased expression of CYGB mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:105,618,325...105,628,091
Ensembl chr10:105,618,326...105,628,091
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity decreases expression increases expression |
ISO EXP |
Diuron results in increased activity of CYP1A1 protein Diuron results in decreased expression of CYP1A1 mRNA Diuron results in increased expression of CYP1A1 mRNA; Diuron results in increased expression of CYP1A1 protein Diuron metabolite results in increased expression of CYP1A1 mRNA; Diuron results in increased expression of CYP1A1 mRNA; Diuron results in increased expression of CYP1A1 protein |
CTD |
PMID:8812189 PMID:16788953 PMID:21551480 PMID:21784029 PMID:24172598 PMID:25152437 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
ISO |
Diuron results in increased expression of CYP1A2 mRNA; Diuron results in increased expression of CYP1A2 protein |
CTD |
PMID:21784029 PMID:22310298 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression decreases expression |
EXP ISO |
Diuron results in increased expression of CYP1B1 mRNA Diuron results in decreased expression of CYP1B1 mRNA Diuron metabolite results in increased expression of CYP1B1 mRNA |
CTD |
PMID:21551480 PMID:24172598 PMID:25152437 |
|
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CYP26B1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:116,261,796...116,278,615
Ensembl chr 4:116,261,796...116,278,615
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
EXP |
Diuron results in increased expression of CYP27A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:81,968,285...81,998,213
Ensembl chr 9:81,968,332...81,998,169
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
Diuron results in increased expression of CYP2B6 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
|
|
G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CYP2U1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:236,414,131...236,431,650
Ensembl chr 2:236,414,135...236,431,683
|
|
G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
decreases expression |
EXP |
Diuron results in decreased expression of CYP3A18 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:10,636,294...10,684,273
Ensembl chr12:10,636,275...10,684,278
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression |
EXP |
Diuron results in increased expression of CYP3A23-3A1 protein |
CTD |
PMID:8812189 |
|
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
increases expression |
ISO |
Diuron results in increased expression of CYP3A4 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
increases expression |
ISO |
Diuron metabolite results in increased expression of CYP4F3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr16:19,501,680...19,528,935
Ensembl chr16:19,410,810...19,528,999
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
EXP |
Diuron results in decreased expression of CYP51 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
|
|
G |
Cytl1 |
cytokine like 1 |
increases expression |
EXP |
Diuron results in increased expression of CYTL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:77,805,137...77,810,147
Ensembl chr14:77,805,130...77,810,147
|
|
G |
Dab2 |
DAB adaptor protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DAB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:55,747,353...55,768,848
Ensembl chr 2:55,747,318...55,768,270
|
|
G |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DACT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:93,740,440...93,751,003
Ensembl chr 6:93,740,586...93,749,809
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DACT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:56,159,435...56,169,443
Ensembl chr 1:56,159,426...56,168,351
|
|
G |
Dap |
death-associated protein |
increases expression |
EXP |
Diuron results in increased expression of DAP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:84,275,884...84,328,998
Ensembl chr 2:84,275,884...84,328,998
|
|
G |
Dbn1 |
drebrin 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DBN1 mRNA Diuron results in decreased expression of DBN1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr17:9,679,511...9,693,878
Ensembl chr17:9,679,628...9,693,820
|
|
G |
Dbnl |
drebrin-like |
increases expression |
EXP |
Diuron results in increased expression of DBNL mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:86,029,335...86,044,364
Ensembl chr14:86,029,335...86,044,364
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
increases expression |
EXP |
Diuron results in increased expression of DBP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:101,687,896...101,692,845
Ensembl chr 1:101,687,855...101,692,846
|
|
G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
decreases expression |
EXP |
Diuron results in decreased expression of DCAF11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:34,233,840...34,244,512
Ensembl chr15:34,234,193...34,244,504
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DCLK1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:144,646,255...144,939,389
Ensembl chr 2:144,646,308...144,936,927
|
|
G |
Dcn |
decorin |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DCN mRNA Diuron results in decreased expression of DCN mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 7:38,742,250...38,782,282
Ensembl chr 7:38,742,051...38,782,323
|
|
G |
Dct |
dopachrome tautomerase |
decreases expression |
EXP |
Diuron results in decreased expression of DCT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:103,208,174...103,245,033
Ensembl chr15:103,208,258...103,244,494
|
|
G |
Dctn3 |
dynactin subunit 3 |
increases expression |
EXP |
Diuron results in increased expression of DCTN3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:58,098,706...58,106,706
Ensembl chr 5:58,098,706...58,106,706
|
|
G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DDAH1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:251,634,368...251,766,009
Ensembl chr 2:251,634,431...251,766,014
|
|
G |
Ddah2 |
dimethylarginine dimethylaminohydrolase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DDAH2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:5,049,260...5,052,573
Ensembl chr20:5,049,496...5,052,585
|
|
G |
Ddb1 |
damage-specific DNA binding protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DDB1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:226,657,561...226,683,356
Ensembl chr 1:226,657,561...226,683,347
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
decreases expression |
EXP |
Diuron results in decreased expression of DDIT4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DDR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:88,311,639...88,436,561
Ensembl chr13:88,317,145...88,436,789
|
|
G |
Ddx5 |
DEAD-box helicase 5 |
decreases expression |
EXP |
Diuron results in decreased expression of DDX5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:94,979,759...94,988,461
Ensembl chr10:94,980,928...94,988,461
|
|
G |
Def8 |
differentially expressed in FDCP 8 homolog |
increases expression |
EXP |
Diuron results in increased expression of DEF8 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:56,238,353...56,259,867
Ensembl chr19:56,243,408...56,259,196
|
|
G |
Depdc7 |
DEP domain containing 7 |
increases expression |
EXP |
Diuron results in increased expression of DEPDC7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:94,665,714...94,687,013
Ensembl chr 3:94,665,717...94,686,989
|
|
G |
Dera |
deoxyribose-phosphate aldolase |
increases expression |
EXP |
Diuron results in increased expression of DERA mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:171,748,254...171,826,414
Ensembl chr 4:171,748,273...171,826,409
|
|
G |
Des |
desmin |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DES mRNA Diuron results in decreased expression of DES mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
increases expression |
EXP |
Diuron results in increased expression of DGAT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:164,113,459...164,143,818
Ensembl chr 1:164,113,459...164,143,818
|
|
G |
Dhrs1 |
dehydrogenase/reductase 1 |
increases expression |
EXP |
Diuron results in increased expression of DHRS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:34,424,017...34,431,302
Ensembl chr15:34,424,016...34,431,325
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of DHRS3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:162,809,090...162,843,385
Ensembl chr 5:162,808,646...162,843,383
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
decreases expression |
EXP |
Diuron results in decreased expression of DHRS4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:34,155,043...34,167,073
Ensembl chr15:34,155,504...34,167,072
|
|
G |
Dhx36 |
DEAH-box helicase 36 |
decreases expression |
EXP |
Diuron results in decreased expression of DHX36 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:152,785,844...152,824,549
Ensembl chr 2:152,785,844...152,824,547
|
|
G |
Dhx40 |
DEAH-box helicase 40 |
increases expression |
EXP |
Diuron results in increased expression of DHX40 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:74,081,442...74,119,032
Ensembl chr10:74,080,590...74,119,032
|
|
G |
Dkk2 |
dickkopf WNT signaling pathway inhibitor 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DKK2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:237,148,918...237,240,883
Ensembl chr 2:237,148,941...237,241,350
|
|
G |
Dlg3 |
discs large MAGUK scaffold protein 3 |
decreases expression |
EXP |
Diuron results in decreased expression of DLG3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:70,596,246...70,648,529
Ensembl chr X:70,596,576...70,648,532
|
|
G |
Dmpk |
DM1 protein kinase |
increases expression |
EXP |
Diuron results in increased expression of DMPK mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:79,988,096...79,999,358
Ensembl chr 1:79,989,019...79,999,364
|
|
G |
Dmxl2 |
Dmx-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DMXL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:58,932,575...59,077,788
Ensembl chr 8:58,932,580...59,077,690
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
increases expression |
EXP |
Diuron results in increased expression of DNAJA1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:57,028,467...57,039,378
Ensembl chr 5:57,028,467...57,039,378
|
|
G |
Dnaja4 |
DnaJ heat shock protein family (Hsp40) member A4 |
decreases expression |
EXP |
Diuron results in decreased expression of DNAJA4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:59,278,262...59,294,003
Ensembl chr 8:59,278,262...59,294,003
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
EXP |
Diuron results in increased expression of DNAJB1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:24,747,178...24,750,919
Ensembl chr19:24,747,178...24,750,919
|
|
G |
Dnajb2 |
DnaJ heat shock protein family (Hsp40) member B2 |
decreases expression |
EXP |
Diuron results in decreased expression of DNAJB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:82,436,453...82,444,669
Ensembl chr 9:82,436,458...82,444,668
|
|
G |
Dnajb3 |
DnaJ heat shock protein family (Hsp40) member B3 |
increases expression |
EXP |
Diuron results in increased expression of DNAJB3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:95,289,918...95,290,931
Ensembl chr 9:95,289,918...95,290,931
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
decreases expression |
EXP |
Diuron results in decreased expression of DNAJC10 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:67,538,289...67,578,308
Ensembl chr 3:67,538,289...67,578,306
|
|
G |
Dnase1l3 |
deoxyribonuclease 1-like 3 |
decreases expression |
EXP |
Diuron results in decreased expression of DNASE1L3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr15:18,710,492...18,736,476
Ensembl chr15:18,710,492...18,736,473
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
increases expression |
ISO |
Diuron metabolite results in increased expression of DNER mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 9:91,965,866...92,291,172
Ensembl chr 9:91,965,866...92,291,220
|
|
G |
Dock11 |
dedicator of cytokinesis 11 |
decreases expression |
EXP |
Diuron results in decreased expression of DOCK11 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr X:122,507,169...122,690,463
Ensembl chr X:122,507,374...122,690,465
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
increases expression decreases expression |
ISO EXP |
Diuron metabolite results in increased expression of DPP4 mRNA Diuron results in decreased expression of DPP4 mRNA |
CTD |
PMID:24172598 PMID:25152437 |
|
NCBI chr 3:48,291,055...48,372,672
Ensembl chr 3:48,291,055...48,372,672
|
|
G |
Dpt |
dermatopontin |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DPT mRNA Diuron results in decreased expression of DPT mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:83,073,307...83,102,404
Ensembl chr13:83,073,544...83,102,401
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DPYSL2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr15:43,475,640...43,581,725
Ensembl chr15:43,477,629...43,542,939
|
|
G |
Dram1 |
DNA-damage regulated autophagy modulator 1 |
increases expression |
EXP |
Diuron results in increased expression of DRAM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:28,898,647...28,932,641
Ensembl chr 7:28,898,649...28,932,641
|
|
G |
Dsel |
dermatan sulfate epimerase-like |
decreases expression |
EXP |
Diuron results in decreased expression of DSEL mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:1,942,384...1,948,563
Ensembl chr13:1,942,499...1,946,508
|
|
G |
Dtnb |
dystrobrevin, beta |
decreases expression |
EXP |
Diuron results in decreased expression of DTNB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:27,975,302...28,177,236
Ensembl chr 6:27,975,417...28,177,214
|
|
G |
Dusp14 |
dual specificity phosphatase 14 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DUSP14 mRNA Diuron metabolite results in decreased expression of DUSP14 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr10:71,363,688...71,383,602
Ensembl chr10:71,363,688...71,383,602
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of DUSP5 mRNA Diuron results in increased expression of DUSP5 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:274,245,184...274,258,595
Ensembl chr 1:274,245,184...274,258,595
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DYNLL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:47,074,200...47,076,573
Ensembl chr12:47,074,200...47,076,572
|
|
G |
Dynll2 |
dynein light chain LC8-type 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DYNLL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:75,262,536...75,281,302
Ensembl chr10:75,262,537...75,270,561
|
|
G |
Dzip3 |
DAZ interacting zinc finger protein 3 |
decreases expression |
EXP |
Diuron results in decreased expression of DZIP3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:54,404,777...54,475,361
Ensembl chr11:54,404,446...54,472,447
|
|
G |
Ebf1 |
EBF transcription factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EBF1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:23,654,849...24,051,627
Ensembl chr10:23,661,013...24,050,209
|
|
G |
Ebf3 |
EBF transcription factor 3 |
decreases expression |
EXP |
Diuron results in decreased expression of EBF3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:209,523,153...209,641,143
Ensembl chr 1:209,523,157...209,641,123
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases expression |
EXP |
Diuron results in increased expression of ECH1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:87,009,798...87,015,996
Ensembl chr 1:87,009,730...87,016,005
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
increases expression |
EXP |
Diuron results in increased expression of ECM2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:15,533,760...15,566,403
Ensembl chr17:15,533,972...15,566,332
|
|
G |
Ecrg4 |
ECRG4 augurin precursor |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ECRG4 mRNA Diuron results in decreased expression of ECRG4 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 9:50,526,811...50,548,056
Ensembl chr 9:50,526,811...50,548,046
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EEF1A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of EEPD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:26,651,241...26,758,330
Ensembl chr 8:26,652,121...26,758,325
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EFEMP1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr14:113,202,382...113,294,993
Ensembl chr14:113,202,419...113,295,014
|
|
G |
Efemp2 |
EGF containing fibulin extracellular matrix protein 2 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of EFEMP2 mRNA Diuron results in decreased expression of EFEMP2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:220,853,695...220,861,420
Ensembl chr 1:220,854,403...220,861,420
|
|
G |
Efhd1 |
EF-hand domain family, member D1 |
decreases expression |
EXP |
Diuron results in decreased expression of EFHD1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:94,362,249...94,408,884
Ensembl chr 9:94,362,299...94,408,885
|
|
G |
Egfl7 |
EGF-like-domain, multiple 7 |
increases expression |
EXP |
Diuron results in increased expression of EGFL7 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:4,034,759...4,044,280
Ensembl chr 3:4,034,921...4,043,936
|
|
G |
Egr2 |
early growth response 2 |
increases expression |
EXP |
Diuron results in increased expression of EGR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025
|
|
G |
Ehd2 |
EH-domain containing 2 |
increases expression |
EXP |
Diuron results in increased expression of EHD2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:77,847,599...77,865,870
Ensembl chr 1:77,847,600...77,865,870
|
|
G |
Eif1 |
eukaryotic translation initiation factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EIF1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:88,227,455...88,229,546
Ensembl chr10:88,227,360...88,229,765
|
|
G |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
decreases expression |
EXP |
Diuron results in decreased expression of EIF2AK4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:110,159,624...110,245,382
Ensembl chr 3:110,159,708...110,249,217
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
increases expression |
EXP |
Diuron results in increased expression of EIF4A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:56,271,257...56,276,764
Ensembl chr10:56,271,257...56,276,764
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
decreases expression |
EXP |
Diuron results in decreased expression of EIF4A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:81,373,047...81,379,680
Ensembl chr11:81,373,048...81,379,871
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
increases expression |
EXP |
Diuron results in increased expression of EIF4B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:143,679,656...143,701,452
Ensembl chr 7:143,679,617...143,701,452
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma, 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EIF4G1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:83,907,659...83,927,683
Ensembl chr11:83,908,109...83,926,524
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
increases expression |
EXP |
Diuron results in increased expression of EIF6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:151,356,867...151,363,201
Ensembl chr 3:151,356,868...151,363,115
|
|
G |
Elf5 |
E74 like ETS transcription factor 5 |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of ELF5 mRNA Diuron results in increased expression of ELF5 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 3:93,333,514...93,374,454
Ensembl chr 3:93,351,619...93,371,656
|
|
G |
Elk3 |
ETS transcription factor ELK3 |
increases expression |
EXP |
Diuron results in increased expression of ELK3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:34,086,213...34,149,601
Ensembl chr 7:34,086,220...34,121,694
|
|
G |
Elmo3 |
engulfment and cell motility 3 |
decreases expression |
EXP |
Diuron results in decreased expression of ELMO3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:37,260,330...37,264,832
Ensembl chr19:37,260,469...37,264,829
|
|
G |
Elovl1 |
ELOVL fatty acid elongase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ELOVL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:137,255,868...137,260,486
Ensembl chr 5:137,255,908...137,260,483
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
decreases expression |
EXP |
Diuron results in decreased expression of ELOVL6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:234,187,490...234,296,124
Ensembl chr 2:234,189,105...234,296,145 Ensembl chr 2:234,189,105...234,296,145
|
|
G |
Emcn |
endomucin |
increases expression |
EXP |
Diuron results in increased expression of EMCN mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:242,634,319...242,715,489
Ensembl chr 2:242,634,399...242,714,182
|
|
G |
Emid1 |
EMI domain containing 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EMID1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:85,357,221...85,400,396
Ensembl chr14:85,357,222...85,398,532
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
increases expression |
EXP |
Diuron results in increased expression of EMILIN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:26,821,249...26,829,013
Ensembl chr 6:26,821,255...26,828,972
|
|
G |
Emilin2 |
elastin microfibril interfacer 2 |
decreases expression |
EXP |
Diuron results in decreased expression of EMILIN2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:119,594,049...119,653,675
Ensembl chr 9:119,594,629...119,653,255
|
|
G |
Eml1 |
EMAP like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EML1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:132,367,342...132,450,488
Ensembl chr 6:132,383,337...132,450,393
|
|
G |
Eml4 |
EMAP like 4 |
decreases expression |
EXP |
Diuron results in decreased expression of EML4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:6,618,370...6,674,550
Ensembl chr 6:6,619,076...6,674,554
|
|
G |
Emp3 |
epithelial membrane protein 3 |
decreases expression |
EXP |
Diuron results in decreased expression of EMP3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:101,900,731...101,903,948
Ensembl chr 1:101,900,733...101,903,910
|
|
G |
Eno1 |
enolase 1 |
increases expression |
EXP |
Diuron results in increased expression of ENO1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ENO2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ENPP2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 7:94,479,931...94,563,086
Ensembl chr 7:94,480,396...94,563,001
|
|
G |
Enpp5 |
ectonucleotide pyrophosphatase/phosphodiesterase family member 5 |
increases expression |
EXP |
Diuron results in increased expression of ENPP5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:19,469,276...19,476,684
Ensembl chr 9:19,469,706...19,476,646
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ENTPD1 mRNA Diuron results in decreased expression of ENTPD1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:259,692,020...259,818,922
Ensembl chr 1:259,739,955...259,819,494
|
|
G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ENTPD2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:2,617,795...2,623,818
Ensembl chr 3:2,617,805...2,623,445
|
|
G |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ENTPD3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:129,201,000...129,232,436
Ensembl chr 8:129,201,669...129,232,677
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
increases expression |
EXP |
Diuron results in increased expression of ENTPD5 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 6:108,087,677...108,123,811
Ensembl chr 6:108,087,418...108,120,579
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of EPB41L2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:20,881,820...21,067,713
Ensembl chr 1:20,893,995...20,962,526
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
Diuron results in increased expression of EPHX1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
increases expression |
EXP |
Diuron results in increased expression of EPHX2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
|
|
G |
Eppk1 |
epiplakin 1 |
increases expression |
EXP |
Diuron results in increased expression of EPPK1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:117,163,383...117,173,741
|
|
G |
Eprs |
glutamyl-prolyl-tRNA synthetase |
decreases expression |
EXP |
Diuron results in decreased expression of EPRS mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:103,300,911...103,371,651
Ensembl chr13:103,300,932...103,371,577
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
increases expression |
EXP |
Diuron results in increased expression of ERGIC3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:151,553,567...151,563,318
Ensembl chr 3:151,553,578...151,563,364
|
|
G |
Erlin1 |
ER lipid raft associated 1 |
increases expression |
EXP |
Diuron results in increased expression of ERLIN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:263,810,439...263,845,762
Ensembl chr 1:263,810,439...263,845,762
|
|
G |
Erp27 |
endoplasmic reticulum protein 27 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of ERP27 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:170,893,946...170,912,629
Ensembl chr 4:170,893,946...170,912,629
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ERRFI1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:167,951,564...167,966,011
Ensembl chr 5:167,952,728...167,966,009
|
|
G |
Esco1 |
establishment of sister chromatid cohesion N-acetyltransferase 1 |
increases expression |
EXP |
Diuron results in increased expression of ESCO1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:1,789,796...1,857,271
Ensembl chr18:1,789,900...1,828,606
|
|
G |
Esd |
esterase D |
decreases expression |
EXP |
Diuron results in decreased expression of ESD mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:56,756,848...56,776,348
Ensembl chr15:56,756,661...56,776,348
|
|
G |
Esrp1 |
epithelial splicing regulatory protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ESRP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:24,576,988...24,631,758
Ensembl chr 5:24,576,991...24,631,698
|
|
G |
Etfbkmt |
electron transfer flavoprotein subunit beta lysine methyltransferase |
increases expression |
EXP |
Diuron results in increased expression of ETFBKMT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:183,655,968...183,665,757
Ensembl chr 4:183,656,013...183,665,754
|
|
G |
Ethe1 |
ETHE1, persulfide dioxygenase |
increases expression |
EXP |
Diuron results in increased expression of ETHE1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:81,457,008...81,472,061
Ensembl chr 1:81,456,984...81,472,097
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
increases expression |
EXP |
Diuron results in increased expression of ETS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:33,756,634...33,879,625
Ensembl chr 8:33,816,386...33,879,625
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
increases expression |
EXP |
Diuron results in increased expression of ETS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:36,075,709...36,092,495
Ensembl chr11:36,075,709...36,092,495
|
|
G |
Eva1b |
eva-1 homolog B |
decreases expression |
EXP |
Diuron results in decreased expression of FAM176B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:144,160,026...144,161,421
Ensembl chr 5:144,160,108...144,161,410
|
|
G |
Exo5 |
exonuclease 5 |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of EXO5 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 5:139,849,930...139,853,247
Ensembl chr 5:139,849,930...139,853,247
|
|
G |
Exoc3 |
exocyst complex component 3 |
increases expression |
EXP |
Diuron results in increased expression of EXOC3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:31,700,953...31,731,726
Ensembl chr 1:31,700,953...31,731,815
|
|
G |
Exosc7 |
exosome component 7 |
increases expression |
EXP |
Diuron results in increased expression of EXOSC7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:132,204,628...132,229,968
Ensembl chr 8:132,204,604...132,229,969
|
|
G |
Ext1 |
exostosin glycosyltransferase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EXT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:92,605,008...92,881,392
Ensembl chr 7:92,605,728...92,882,068
|
|
G |
Ezh1 |
enhancer of zeste 1 polycomb repressive complex 2 subunit |
decreases expression |
EXP |
Diuron results in decreased expression of EZH1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:89,104,026...89,139,978
Ensembl chr10:89,104,027...89,130,339
|
|
G |
Ezr |
ezrin |
increases expression |
EXP |
Diuron results in increased expression of EZR mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
decreases expression |
EXP |
Diuron results in decreased expression of F13A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr17:28,504,650...28,680,015
Ensembl chr17:28,504,623...28,680,362
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
increases expression |
EXP |
Diuron results in increased expression of F2R mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression |
EXP |
Diuron results in decreased expression of F3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
Faah |
fatty acid amide hydrolase |
increases expression |
EXP |
Diuron results in increased expression of FAAH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:134,852,899...134,872,095
Ensembl chr 5:134,852,875...134,871,775
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
increases expression |
EXP |
Diuron results in increased expression of FABP5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:93,981,662...93,985,322
Ensembl chr 2:93,981,656...93,985,378
|
|
G |
Fads2 |
fatty acid desaturase 2 |
increases expression |
EXP |
Diuron results in increased expression of FADS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:225,906,582...226,152,568
Ensembl chr 1:226,114,413...226,152,524
|
|
G |
Fam102b |
family with sequence similarity 102, member B |
decreases expression |
EXP |
Diuron results in decreased expression of FAM102B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:211,762,479...211,831,837
Ensembl chr 2:211,772,128...211,831,636
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
decreases expression |
EXP |
Diuron results in decreased expression of FAM114A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:44,941,705...45,012,299
Ensembl chr14:44,943,172...45,002,719
|
|
G |
Fam118a |
family with sequence similarity 118, member A |
increases expression |
EXP |
Diuron results in increased expression of FAM118A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:125,937,928...125,964,455
Ensembl chr 7:125,937,928...125,964,453
|
|
G |
Fam136a |
family with sequence similarity 136, member A |
increases expression |
EXP |
Diuron results in increased expression of FAM136A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:118,160,147...118,166,062
Ensembl chr 4:118,160,147...118,166,062
|
|
G |
Fam171b |
family with sequence similarity 171, member B |
decreases expression |
EXP |
Diuron results in decreased expression of FAM171B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:71,210,048...71,265,419
Ensembl chr 3:71,210,301...71,262,615
|
|
G |
Fam174c |
family with sequence similarity 174 member C |
decreases expression |
EXP |
Diuron results in decreased expression of FAM174C mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:12,398,200...12,399,910
Ensembl chr 7:12,398,200...12,399,910
|
|
G |
Fam189a2 |
family with sequence similarity 189, member A2 |
decreases expression |
EXP |
Diuron results in decreased expression of FAM189A2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:241,822,152...241,876,089
Ensembl chr 1:241,822,626...241,875,864
|
|
G |
Fam214a |
family with sequence similarity 214, member A |
increases expression |
EXP |
Diuron results in increased expression of FAM214A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:81,863,619...81,941,548
Ensembl chr 8:81,863,619...81,941,536
|
|
G |
Fam25a |
family with sequence similarity 25, member A |
decreases expression |
EXP |
Diuron results in decreased expression of FAM25A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:10,702,264...10,706,073
Ensembl chr16:10,702,263...10,706,073
|
|
G |
Fam3b |
FAM3 metabolism regulating signaling molecule B |
increases expression |
EXP |
Diuron results in increased expression of FAM3B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:37,922,308...37,993,279
Ensembl chr11:37,922,292...37,993,207
|
|
G |
Fam83f |
family with sequence similarity 83, member F |
increases expression |
EXP |
Diuron results in increased expression of FAM83F mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:121,889,157...121,918,772
Ensembl chr 7:121,889,157...121,918,772
|
|
G |
Fam91a1 |
family with sequence similarity 91, member A1 |
increases expression |
EXP |
Diuron results in increased expression of FAM91A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:98,302,803...98,341,201
Ensembl chr 7:98,302,953...98,342,367
|
|
G |
Fam98a |
family with sequence similarity 98, member A |
decreases expression |
EXP |
Diuron results in decreased expression of FAM98A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:21,051,327...21,065,986
Ensembl chr 6:21,051,327...21,065,986
|
|
G |
Fap |
fibroblast activation protein, alpha |
decreases expression |
EXP |
Diuron results in decreased expression of FAP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:48,467,781...48,536,242
Ensembl chr 3:48,467,781...48,536,235
|
|
G |
Farp1 |
FERM, ARH/RhoGEF and pleckstrin domain protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FARP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:106,375,298...106,625,837
Ensembl chr15:106,434,177...106,625,837
|
|
G |
Fas |
Fas cell surface death receptor |
decreases expression |
EXP |
Diuron results in decreased expression of FAS mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
EXP |
Diuron results in increased expression of FBLN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:126,096,793...126,176,468
Ensembl chr 7:126,096,793...126,176,468
|
|
G |
Fbln2 |
fibulin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FBLN2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:122,835,237...122,895,127
Ensembl chr 4:122,835,436...122,895,121
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FBN1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120
|
|
G |
Fbxl22 |
F-box and leucine-rich repeat protein 22 |
increases expression |
EXP |
Diuron results in increased expression of FBXL22 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:72,198,043...72,204,730
Ensembl chr 8:72,198,043...72,204,730
|
|
G |
Fbxo22 |
F-box protein 22 |
decreases expression |
EXP |
Diuron results in decreased expression of FBXO22 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:59,770,032...59,786,061
Ensembl chr 8:59,769,994...59,786,065
|
|
G |
Fbxo6 |
F-box protein 6 |
increases expression |
EXP |
Diuron results in increased expression of FBXO6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:164,956,285...164,962,075
Ensembl chr 5:164,956,280...164,959,851
|
|
G |
Fcer1g |
Fc fragment of IgE receptor Ig |
decreases expression |
EXP |
Diuron results in decreased expression of FCER1G mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:89,601,894...89,606,326
Ensembl chr13:89,601,896...89,606,326
|
|
G |
Fcgr2a |
Fc fragment of IgG receptor IIa |
decreases expression |
EXP |
Diuron results in decreased expression of FCGR2A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:91,146,878...91,163,691
Ensembl chr13:91,168,973...91,198,036 Ensembl chr13:91,168,973...91,198,036
|
|
G |
Fcmr |
Fc fragment of IgM receptor |
decreases expression |
EXP |
Diuron results in decreased expression of FCMR mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:47,602,701...47,617,065
Ensembl chr13:47,602,692...47,617,064
|
|
G |
Fcna |
ficolin A |
decreases expression |
EXP |
Diuron results in decreased expression of FCNA mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:2,850,006...2,853,230
Ensembl chr 3:2,849,984...2,853,272
|
|
G |
Fcrl2 |
Fc receptor-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FCRLS mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:186,594,442...186,605,115
Ensembl chr 2:186,595,051...186,606,172
|
|
G |
Fdps |
farnesyl diphosphate synthase |
decreases expression |
EXP |
Diuron results in decreased expression of FDPS mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
|
|
G |
Fem1b |
fem-1 homolog B |
increases expression |
EXP |
Diuron results in increased expression of FEM1B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:67,695,041...67,708,313
Ensembl chr 8:67,694,904...67,708,304
|
|
G |
Fermt2 |
fermitin family member 2 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of FERMT2 mRNA Diuron results in decreased expression of FERMT2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr15:19,807,806...19,876,557
Ensembl chr15:19,807,808...19,876,408
|
|
G |
Fez2 |
fasciculation and elongation protein zeta 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FEZ2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:963,903...1,003,955
Ensembl chr 6:963,907...1,004,001
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FGF1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
decreases expression |
EXP |
Diuron results in decreased expression of FGF18 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:18,047,109...18,082,290
Ensembl chr10:18,047,109...18,063,391
|
|
G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of FGFBP1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr14:71,647,429...71,650,359
Ensembl chr14:71,649,274...71,650,354
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FGFR1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
EXP |
Diuron results in decreased expression of FGG mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:181,987,080...181,994,523
Ensembl chr 2:181,987,217...181,994,514
|
|
G |
Fgl2 |
fibrinogen-like 2 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of FGL2 mRNA Diuron results in decreased expression of FGL2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:10,323,598...10,329,241
Ensembl chr 4:10,323,607...10,329,241
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of FHL1 mRNA Diuron results in decreased expression of FHL1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr X:159,112,516...159,172,528
Ensembl chr X:159,112,880...159,172,524
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
increases expression |
EXP |
Diuron results in increased expression of FHL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:49,920,611...49,994,906
Ensembl chr 9:49,920,854...49,950,093
|
|
G |
Fibin |
fin bud initiation factor homolog |
decreases expression |
EXP |
Diuron results in decreased expression of FIBIN mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:101,545,207...101,547,478
Ensembl chr 3:101,545,208...101,547,478
|
|
G |
Fibp |
FGF1 intracellular binding protein |
increases expression |
EXP |
Diuron results in increased expression of FIBP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:220,840,078...220,844,412
Ensembl chr 1:220,840,118...220,844,405
|
|
G |
Filip1l |
filamin A interacting protein 1-like |
increases expression |
EXP |
Diuron results in increased expression of FILIP1L mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:45,039,488...45,275,141
Ensembl chr11:45,039,461...45,124,423
|
|
G |
Fis1 |
fission, mitochondrial 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FIS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:22,750,485...22,765,324
Ensembl chr12:22,750,485...22,765,308
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
decreases expression |
EXP |
Diuron results in decreased expression of FKBP11 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:140,398,253...140,402,664
Ensembl chr 7:140,398,199...140,437,467
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression |
EXP |
Diuron results in increased expression of FKBP1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:147,042,944...147,062,725
Ensembl chr 3:147,042,944...147,062,724
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of FKBP1B mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 6:29,975,863...29,987,252
Ensembl chr 6:29,977,797...29,987,451
|
|
G |
Fkbp2 |
FKBP prolyl isomerase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FKBP2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:222,232,349...222,235,113
Ensembl chr 1:222,232,351...222,235,102
|
|
G |
Flcn |
folliculin |
decreases expression |
EXP |
Diuron results in decreased expression of FLCN mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:46,153,185...46,172,331
Ensembl chr10:46,153,188...46,172,309
|
|
G |
Flna |
filamin A |
increases expression |
EXP |
Diuron results in increased expression of FLNA mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:156,460,785...156,487,245
Ensembl chr X:156,463,953...156,487,245
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
increases expression |
EXP |
Diuron results in increased expression of FLT1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905
|
|
G |
Fmnl2 |
formin-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FMNL2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:38,400,409...38,677,637
Ensembl chr 3:38,559,914...38,675,878
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FMO2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:80,752,526...80,775,264
Ensembl chr13:80,755,058...80,775,264
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of FMO3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:80,837,418...80,856,214
Ensembl chr13:80,837,420...80,862,963
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
increases expression |
EXP |
Diuron results in increased expression of FMO5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:199,796,870...199,823,927
Ensembl chr 2:199,796,881...199,823,927
|
|
G |
Fmod |
fibromodulin |
decreases expression |
EXP |
Diuron results in decreased expression of FMOD mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:50,874,886...50,885,503
Ensembl chr13:50,873,605...50,885,563
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FN1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Fndc1 |
fibronectin type III domain containing 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FNDC1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:47,605,211...47,687,499
Ensembl chr 1:47,605,262...47,687,504
|
|
G |
Folr2 |
folate receptor beta |
decreases expression |
EXP |
Diuron results in decreased expression of FOLR2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:166,915,045...166,933,377
Ensembl chr 1:166,915,045...166,919,302
|
|
G |
Foxn3 |
forkhead box N3 |
decreases expression |
EXP |
Diuron results in decreased expression of FOXN3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:123,183,720...123,577,719
Ensembl chr 6:123,187,726...123,577,695
|
|
G |
Foxp1 |
forkhead box P1 |
decreases expression |
EXP |
Diuron results in decreased expression of FOXP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:131,362,178...131,963,466
Ensembl chr 4:131,366,744...131,694,755
|
|
G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
increases expression |
EXP |
Diuron results in increased expression of FRS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:60,128,506...60,210,482
Ensembl chr 7:60,128,508...60,210,518
|
|
G |
Fry |
FRY microtubule binding protein |
increases expression |
EXP |
Diuron results in increased expression of FRY mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:5,573,729...5,822,874
Ensembl chr12:5,573,729...5,822,874
|
|
G |
Fst |
follistatin |
decreases expression |
EXP |
Diuron results in decreased expression of FST mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:46,537,589...46,544,813
Ensembl chr 2:46,538,700...46,544,457
|
|
G |
Fstl1 |
follistatin-like 1 |
increases expression decreases expression |
EXP ISO |
Diuron results in increased expression of FSTL1 mRNA Diuron results in decreased expression of FSTL1 mRNA Diuron metabolite results in decreased expression of FSTL1 mRNA |
CTD |
PMID:21551480 PMID:24172598 PMID:25152437 |
|
NCBI chr11:65,791,196...65,845,721
Ensembl chr11:65,782,567...65,845,418
|
|
G |
Fuca2 |
alpha-L-fucosidase 2 |
increases expression |
EXP |
Diuron results in increased expression of FUCA2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:7,658,919...7,673,663
Ensembl chr 1:7,658,890...7,673,683
|
|
G |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of FXYD1 mRNA Diuron results in decreased expression of FXYD1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:89,484,197...89,488,279
Ensembl chr 1:89,484,199...89,488,223
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FXYD2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:49,710,334...49,717,492
Ensembl chr 8:49,710,477...49,716,955
|
|
G |
Fxyd3 |
FXYD domain-containing ion transport regulator 3 |
increases expression |
EXP |
Diuron results in increased expression of FXYD3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:89,502,561...89,510,146
Ensembl chr 1:89,502,562...89,509,343
|
|
G |
Fxyd4 |
FXYD domain-containing ion transport regulator 4 |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of FXYD4 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:149,984,206...149,988,744
Ensembl chr 4:149,984,206...149,988,295
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
increases expression |
EXP |
Diuron results in increased expression of FXYD5 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:89,464,853...89,474,450
Ensembl chr 1:89,464,860...89,474,252
|
|
G |
Fyb1 |
FYN binding protein 1 |
increases expression |
ISO |
Diuron metabolite results in increased expression of FYB1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:55,834,904...55,983,805
Ensembl chr 2:55,835,151...55,983,804
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
decreases expression |
EXP |
Diuron results in decreased expression of FYN mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
|
|
G |
G0s2 |
G0/G1switch 2 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of G0S2 mRNA Diuron results in decreased expression of G0S2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
EXP |
Diuron results in increased expression of G6PD mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
|
|
G |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
increases expression |
EXP |
Diuron results in increased expression of GALNT11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:6,297,255...6,330,765
Ensembl chr 4:6,297,258...6,330,765
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
decreases expression |
EXP |
Diuron results in decreased expression of GALNT16 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:104,069,853...104,250,177
Ensembl chr 6:104,068,547...104,250,174
|
|
G |
Gap43 |
growth associated protein 43 |
decreases expression |
EXP |
Diuron results in decreased expression of GAP43 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:58,624,198...58,717,916
Ensembl chr11:58,624,198...58,717,914
|
|
G |
Gas5 |
growth arrest specific 5 |
decreases expression |
EXP |
Diuron results in decreased expression of GAS5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:78,852,523...78,855,844
|
|
G |
Gas6 |
growth arrest specific 6 |
decreases expression |
EXP |
Diuron results in decreased expression of GAS6 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:81,213,364...81,243,824
Ensembl chr16:81,213,364...81,243,757
|
|
G |
Gask1b |
golgi associated kinase 1B |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of GASK1B mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:178,678,946...178,751,459
Ensembl chr 2:178,679,041...178,750,668
|
|
G |
Gata3 |
GATA binding protein 3 |
decreases expression |
EXP |
Diuron results in decreased expression of GATA3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
|
|
G |
Gatad1 |
GATA zinc finger domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of GATAD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:27,647,005...27,658,533
Ensembl chr 4:27,647,335...27,657,167
|
|
G |
Gbf1 |
golgi brefeldin A resistant guanine nucleotide exchange factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GBF1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:265,904,616...266,033,107
Ensembl chr 1:265,904,566...266,033,156
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GBP2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:248,276,795...248,293,784
Ensembl chr 2:248,276,709...248,293,784
|
|
G |
Gca |
grancalcin |
decreases expression |
EXP |
Diuron results in decreased expression of GCA mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:48,625,965...48,661,317
Ensembl chr 3:48,626,038...48,661,317
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
EXP |
Diuron results in increased expression of GCLC mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2 (I blood group) |
decreases expression |
EXP |
Diuron results in decreased expression of GCNT2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr17:21,634,546...21,677,477
Ensembl chr17:21,634,551...21,739,408
|
|
G |
Gda |
guanine deaminase |
decreases expression |
EXP |
Diuron results in decreased expression of GDA mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
|
|
G |
Gde1 |
glycerophosphodiester phosphodiesterase 1 |
increases expression |
EXP |
Diuron results in increased expression of GDE1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:188,367,550...188,407,125
Ensembl chr 1:188,394,814...188,407,132
|
|
G |
Gdf10 |
growth differentiation factor 10 |
decreases expression |
EXP |
Diuron results in decreased expression of GDF10 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:10,250,508...10,262,383
Ensembl chr16:10,250,404...10,263,150
|
|
G |
Gdf11 |
growth differentiation factor 11 |
increases expression |
EXP |
Diuron results in increased expression of GDF11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:3,306,863...3,315,856
Ensembl chr 7:3,306,863...3,315,856
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
EXP |
Diuron metabolite results in increased expression of GDF15 mRNA; Diuron results in increased expression of GDF15 mRNA |
CTD |
PMID:24172598 PMID:25152437 |
|
NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GDI1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:156,400,734...156,407,396
Ensembl chr X:156,400,736...156,407,404
|
|
G |
Gdpd2 |
glycerophosphodiester phosphodiesterase domain containing 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GDPD2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:70,563,381...70,572,295
Ensembl chr X:70,563,570...70,572,295
|
|
G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
decreases expression |
EXP |
Diuron results in decreased expression of GDPD3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:198,199,032...198,209,178
Ensembl chr 1:198,199,622...198,209,150
|
|
G |
Gfpt2 |
glutamine-fructose-6-phosphate transaminase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GFPT2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr10:35,279,237...35,325,506
Ensembl chr10:35,279,236...35,325,508
|
|
G |
Ggct |
gamma-glutamyl cyclotransferase |
decreases expression |
EXP |
Diuron results in decreased expression of GGCT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:85,186,644...85,192,857
Ensembl chr 4:85,186,644...85,192,834
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
increases expression |
EXP |
Diuron results in increased expression of GGH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:34,040,258...34,063,369
Ensembl chr 5:34,040,258...34,063,361
|
|
G |
Ghr |
growth hormone receptor |
decreases expression |
EXP |
Diuron results in decreased expression of GHR mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:53,149,225...53,413,954
Ensembl chr 2:53,150,370...53,413,638
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases expression |
EXP |
Diuron results in increased expression of GJA1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
|
|
G |
Gjb6 |
gap junction protein, beta 6 |
increases expression |
EXP ISO |
Diuron results in increased expression of GJB6 mRNA Diuron metabolite results in increased expression of GJB6 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr15:37,400,888...37,411,656
Ensembl chr15:37,400,889...37,410,848
|
|
G |
Gkn1 |
gastrokine 1 |
increases expression |
EXP |
Diuron results in increased expression of GKN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:119,143,070...119,148,358
Ensembl chr 4:119,143,070...119,148,358
|
|
G |
Gkn2 |
gastrokine 2 |
increases expression |
EXP |
Diuron results in increased expression of GKN2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:119,131,255...119,177,329
Ensembl chr 4:119,171,245...119,177,329
|
|
G |
Glb1l2 |
galactosidase, beta 1-like 2 |
increases expression |
EXP |
Diuron results in increased expression of GLB1L2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:27,805,139...27,853,080
Ensembl chr 8:27,807,301...27,852,996
|
|
G |
Glce |
glucuronic acid epimerase |
increases expression |
EXP |
Diuron results in increased expression of GLCE mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:67,006,588...67,073,723
Ensembl chr 8:67,006,592...67,040,005
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
increases expression |
EXP |
Diuron results in increased expression of GLIPR1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:54,767,828...54,778,823
Ensembl chr 7:54,767,827...54,778,848
|
|
G |
Glis2 |
GLIS family zinc finger 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GLIS2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:11,154,459...11,177,063
Ensembl chr10:11,154,658...11,174,861
|
|
G |
Glrx |
glutaredoxin |
increases expression |
EXP |
Diuron results in increased expression of GLRX mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:2,606,032...2,615,944
Ensembl chr 2:2,605,996...2,615,944
|
|
G |
Glrx2 |
glutaredoxin 2 |
increases expression |
EXP |
Diuron results in increased expression of GLRX2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:60,529,057...60,552,115
Ensembl chr13:60,529,932...60,537,916
|
|
G |
Gls |
glutaminase |
decreases expression |
EXP |
Diuron results in decreased expression of GLS mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:54,212,622...54,284,879
Ensembl chr 9:54,212,767...54,284,872
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
increases expression |
EXP |
Diuron results in increased expression of GLUD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:10,661,486...10,695,557
Ensembl chr16:10,662,021...10,695,557
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases expression |
EXP |
Diuron results in decreased expression of GLUL mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:71,331,052...71,340,207
Ensembl chr13:71,331,052...71,340,229
|
|
G |
Gm2a |
GM2 ganglioside activator |
decreases expression |
EXP |
Diuron results in decreased expression of GM2A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:40,438,394...40,450,927
Ensembl chr10:40,438,356...40,450,930
|
|
G |
Gnai1 |
G protein subunit alpha i1 |
decreases expression |
EXP |
Diuron results in decreased expression of GNAI1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:13,405,136...13,486,866
Ensembl chr 4:13,405,136...13,485,883
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
decreases expression |
EXP |
Diuron results in decreased expression of GNAI3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:210,896,779...210,934,733
Ensembl chr 2:210,896,656...210,934,749
|
|
G |
Gng11 |
G protein subunit gamma 11 |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of GNG11 mRNA Diuron results in increased expression of GNG11 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:28,989,170...28,994,610
Ensembl chr 4:28,989,115...28,993,621
|
|
G |
Golph3l |
golgi phosphoprotein 3-like |
decreases expression |
EXP |
Diuron results in decreased expression of GOLPH3L mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:197,720,259...197,749,060
Ensembl chr 2:197,715,761...197,750,115
|
|
G |
Golt1a |
golgi transport 1A |
increases expression |
EXP |
Diuron results in increased expression of GOLT1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:50,532,116...50,550,029
Ensembl chr13:50,537,133...50,550,015
|
|
G |
Gorasp1 |
golgi reassembly stacking protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GORASP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:128,610,290...128,622,337
Ensembl chr 8:128,610,291...128,622,337
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GOT1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:263,246,248...263,269,762
Ensembl chr 1:263,246,248...263,269,762
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
increases expression |
EXP |
Diuron results in increased expression of GOT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:9,587,637...9,613,323
Ensembl chr19:9,587,653...9,613,340
|
|
G |
Gpatch4 |
G patch domain containing 4 |
decreases expression |
EXP |
Diuron results in decreased expression of GPATCH4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:187,404,731...187,424,047
Ensembl chr 2:187,415,262...187,424,045
|
|
G |
Gpc3 |
glypican 3 |
decreases expression |
EXP |
Diuron results in decreased expression of GPC3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr X:139,579,268...139,947,093
Ensembl chr X:139,579,268...139,916,883
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GPD1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928
|
|
G |
Gpm6a |
glycoprotein m6a |
decreases expression |
EXP |
Diuron results in decreased expression of GPM6A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:39,367,697...39,719,292
Ensembl chr16:39,367,692...39,719,187
|
|
G |
Gprasp2 |
G protein-coupled receptor associated sorting protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GPRASP2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:106,357,240...106,363,455
Ensembl chr X:106,360,393...106,363,300
|
|
G |
Gpsm2 |
G-protein signaling modulator 2 |
increases expression |
EXP |
Diuron results in increased expression of GPSM2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:211,480,120...211,528,096
Ensembl chr 2:211,480,400...211,527,919
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
decreases expression |
EXP |
Diuron results in decreased expression of GPT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of GPX3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:40,247,436...40,255,423
Ensembl chr10:40,247,436...40,255,422
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression |
EXP |
Diuron results in decreased expression of GPX4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
decreases expression |
EXP |
Diuron results in decreased expression of GPX7 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:128,001,766...128,009,610
Ensembl chr 5:128,001,761...128,009,735
|
|
G |
Gpx8 |
glutathione peroxidase 8 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of GPX8 mRNA Diuron results in decreased expression of GPX8 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:44,903,337...44,907,046
Ensembl chr 2:44,903,337...44,907,030
|
|
G |
Gramd1c |
GRAM domain containing 1C |
increases expression |
EXP |
Diuron results in increased expression of GRAMD1C mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:61,609,370...61,659,355 NCBI chr11:62,580,983...62,634,961
Ensembl chr11:61,605,937...62,634,803
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
decreases expression |
EXP |
Diuron results in decreased expression of GRB10 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:92,021,851...92,122,249
Ensembl chr14:92,021,851...92,117,923
|
|
G |
Grhl3 |
grainyhead-like transcription factor 3 |
increases expression |
EXP |
Diuron results in increased expression of GRHL3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:153,893,039...153,925,045
Ensembl chr 5:153,893,039...153,924,896
|
|
G |
Grhpr |
glyoxylate and hydroxypyruvate reductase |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of GRHPR mRNA Diuron results in increased expression of GRHPR mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 5:60,528,981...60,538,410
Ensembl chr 5:60,528,997...60,538,375
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GRINA mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:117,304,742...117,307,916
Ensembl chr 7:117,304,742...117,307,916
|
|
G |
Grk5 |
G protein-coupled receptor kinase 5 |
increases expression |
EXP |
Diuron results in increased expression of GRK5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:282,265,371...282,467,842
Ensembl chr 1:282,265,370...282,462,605
|
|
G |
Grtp1 |
growth hormone regulated TBC protein 1 |
increases expression |
EXP |
Diuron results in increased expression of GRTP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:81,665,533...81,689,525
Ensembl chr16:81,665,540...81,688,148
|
|
G |
Gsn |
gelsolin |
decreases expression |
EXP |
Diuron results in decreased expression of GSN mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
|
|
G |
Gspt2 |
G1 to S phase transition 2 |
increases expression |
EXP |
Diuron results in increased expression of GSPT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:63,959,131...63,961,652
Ensembl chr X:63,954,727...63,961,613
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
EXP |
Diuron results in increased expression of GSR mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression affects expression |
EXP |
Diuron results in increased expression of GSTA2 mRNA; Diuron results in increased expression of GSTA3 mRNA Diuron affects the expression of GSTA2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 8:85,640,081...85,645,621
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
increases expression |
EXP |
Diuron results in increased expression of GSTA4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:85,497,557...85,514,732
Ensembl chr 8:85,497,557...85,518,879
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
Diuron results in increased expression of GSTA5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GSTK1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:71,621,777...71,626,096
Ensembl chr 4:71,621,729...71,626,107
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
EXP |
Diuron results in increased expression of GSTM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstm3l |
glutathione S-transferase mu 3-like |
decreases expression |
EXP |
Diuron results in decreased expression of GSTM5 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:210,761,729...210,766,501
Ensembl chr 2:210,761,729...210,766,501
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GSTO1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:267,607,437...267,617,387
Ensembl chr 1:267,607,418...267,617,387
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
Diuron results in increased expression of GSTP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gtf2b |
general transcription factor IIB |
increases expression |
EXP |
Diuron results in increased expression of GTF2B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:248,709,433...248,727,741
Ensembl chr 2:248,715,281...248,727,741
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GUCY1A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:181,045,694...181,103,321
Ensembl chr 2:181,045,703...181,102,918
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GULP1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:51,263,484...51,538,066
Ensembl chr 9:51,263,622...51,538,072
|
|
G |
H1f0 |
H1.0 linker histone |
increases expression |
EXP |
Diuron results in increased expression of H1F0 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:120,260,776...120,262,636
|
|
G |
H2az1 |
H2A.Z variant histone 1 |
increases expression |
EXP |
Diuron results in increased expression of H2AZ1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:243,105,224...243,107,333
Ensembl chr 2:243,105,674...243,106,956
|
|
G |
H3f3b |
H3.3 histone B |
increases expression |
EXP |
Diuron results in increased expression of H3F3B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:104,573,666...104,575,890
Ensembl chr10:104,573,664...104,575,890
|
|
G |
Hacd1 |
3-hydroxyacyl-CoA dehydratase 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of HACD1 mRNA Diuron results in decreased expression of HACD1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr17:81,173,238...81,196,012
Ensembl chr17:81,173,713...81,187,739
|
|
G |
Hap1 |
huntingtin-associated protein 1 |
increases expression |
EXP |
Diuron results in increased expression of HAP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:88,257,975...88,266,210
Ensembl chr10:88,257,976...88,266,210
|
|
G |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
decreases expression |
EXP |
Diuron results in decreased expression of HAPLN4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:21,081,377...21,089,508
Ensembl chr16:21,081,377...21,089,508
|
|
G |
Has2 |
hyaluronan synthase 2 |
increases expression |
ISO |
Diuron metabolite results in increased expression of HAS2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 7:96,438,046...96,464,049
Ensembl chr 7:96,438,046...96,464,049
|
|
G |
Hdac2 |
histone deacetylase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of HDAC2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:43,084,870...43,108,198
Ensembl chr20:43,084,870...43,108,198
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
increases expression |
EXP |
Diuron results in increased expression of HES1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:74,312,837...74,315,249
Ensembl chr11:74,312,806...74,315,248
|
|
G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
decreases expression |
EXP |
Diuron results in decreased expression of HIBADH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:82,604,369...82,702,429
Ensembl chr 4:82,604,373...82,702,429
|
|
G |
Higd1a |
HIG1 hypoxia inducible domain family, member 1A |
increases expression |
EXP |
Diuron results in increased expression of HIGD1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:130,482,492...130,491,888
Ensembl chr 8:130,482,493...130,491,998
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
increases expression decreases expression |
EXP |
Diuron results in increased expression of HIST1H4B mRNA Diuron results in decreased expression of HIST1H4B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:44,522,144...44,526,587
Ensembl chr17:44,522,140...44,526,583
|
|
G |
Hist2h2be |
histone cluster 2 H2B family member E |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of HIST2H2BE mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:198,360,837...198,363,399
Ensembl chr 2:198,360,998...198,361,378
|
|
G |
Hist2h3c2 |
histone cluster 2 H3 family member C2 |
increases expression |
EXP |
Diuron results in increased expression of H3C7 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:198,390,024...198,418,075
Ensembl chr 2:198,417,619...198,418,029
|
|
G |
Hk3 |
hexokinase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of HK3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:10,134,726...10,152,976
Ensembl chr17:10,137,974...10,152,956
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
EXP |
Diuron results in increased expression of HMGCS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of HMGCS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:200,452,623...200,480,785
Ensembl chr 2:200,452,624...200,479,423
|
|
G |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
decreases expression |
EXP |
Diuron results in decreased expression of HMGN2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:152,195,359...152,198,813
Ensembl chr 5:152,195,361...152,198,813
|
|
G |
Hmgxb4 |
HMG-box containing 4 |
decreases expression |
EXP |
Diuron results in decreased expression of HMGXB4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:14,352,644...14,390,499
Ensembl chr19:14,352,411...14,390,478
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPA1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:144,865,302...144,871,592
Ensembl chr 7:144,865,608...144,871,585
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPA2B1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:81,237,496...81,241,281
Ensembl chr 4:81,237,496...81,241,282
|
|
G |
Hnrnpa3 |
heterogeneous nuclear ribonucleoprotein A3 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPA3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:62,481,222...62,491,356
Ensembl chr 3:62,481,323...62,487,227
|
|
G |
Hnrnpd |
heterogeneous nuclear ribonucleoprotein D |
increases expression |
EXP |
Diuron results in increased expression of HNRNPD mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:11,256,163...11,274,684
Ensembl chr14:11,256,268...11,274,578
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPH1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:35,872,619...35,879,911
Ensembl chr10:35,870,232...35,879,910
|
|
G |
Hnrnph3 |
heterogeneous nuclear ribonucleoprotein H3 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPH3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:27,167,926...27,178,172
Ensembl chr20:27,169,267...27,216,941
|
|
G |
Hopx |
HOP homeobox |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of HOPX mRNA Diuron results in increased expression of HOPX mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr14:33,354,803...33,362,547
Ensembl chr14:33,354,807...33,362,551
|
|
G |
Hoxa3 |
homeobox A3 |
decreases expression |
EXP |
Diuron results in decreased expression of HOXA3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:82,137,802...82,181,836
Ensembl chr 4:82,138,683...82,141,385
|
|
G |
Hoxa5 |
homeo box A5 |
decreases expression |
EXP |
Diuron results in decreased expression of HOXA5 mRNA |
CTD |
PMID:21551480 |
|
|
|
G |
Hoxa9 |
homeobox A9 |
decreases expression |
EXP |
Diuron results in decreased expression of HOXA9 mRNA |
CTD |
PMID:21551480 |
|
|
|
G |
Hoxb3 |
homeo box B3 |
decreases expression |
EXP |
Diuron results in decreased expression of HOXB3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:84,170,629...84,196,823
Ensembl chr10:84,182,118...84,195,796
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of HPCAL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:43,001,920...43,109,083
Ensembl chr 6:43,001,948...43,109,071
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
decreases expression increases expression |
EXP ISO |
Diuron results in decreased expression of HPGD mRNA Diuron metabolite results in increased expression of HPGD mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr16:37,457,134...37,495,758
Ensembl chr16:37,457,135...37,495,758
|
|
G |
Hrh3 |
histamine receptor H3 |
decreases expression |
EXP |
Diuron results in decreased expression of HRH3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:175,474,310...175,479,395
Ensembl chr 3:175,473,078...175,479,395
|
|
G |
Hscb |
HscB mitochondrial iron-sulfur cluster co-chaperone |
increases expression |
EXP |
Diuron results in increased expression of HSCB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:51,878,267...51,888,645
Ensembl chr12:51,878,153...51,888,669
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
increases expression |
EXP |
Diuron results in increased expression of HSD11B1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:111,946,626...111,996,536
Ensembl chr13:111,926,442...111,972,603
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
decreases expression |
EXP |
Diuron results in decreased expression of HSD17B10 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:21,696,796...21,699,241
Ensembl chr X:21,696,772...21,699,241
|
|
G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
increases expression |
EXP |
Diuron results in increased expression of HSD17B11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:7,054,724...7,104,567
Ensembl chr14:7,073,445...7,104,566
|
|
G |
Hsd17b13 |
hydroxysteroid (17-beta) dehydrogenase 13 |
increases expression |
EXP |
Diuron results in increased expression of HSD17B13 mRNA |
CTD |
PMID:2 | |